CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
G
Akt1
thymoma viral proto-oncogene 1
multiple interactions
EXP
1,3-dinitropyrene results in increased phosphorylation of and results in increased activity of AKT1 protein
CTD
PMID:17240030
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
Bad
BCL2-associated agonist of cell death
decreases phosphorylation increases phosphorylation
EXP
1,3-dinitropyrene results in decreased phosphorylation of BAD protein 1,3-dinitropyrene results in increased phosphorylation of BAD protein
CTD
PMID:17240030
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
G
Bcl2l1
BCL2-like 1
decreases expression
EXP
1,3-dinitropyrene results in decreased expression of BCL2L1 protein
CTD
PMID:17240030
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
G
Bid
BH3 interacting domain death agonist
decreases expression
EXP
1,3-dinitropyrene results in decreased expression of BID protein
CTD
PMID:17240030
NCBI chr 6:120,870,080...120,894,074
Ensembl chr 6:120,868,891...120,893,814
G
Casp3
caspase 3
multiple interactions
EXP
1,3-dinitropyrene results in increased cleavage of and results in increased activity of CASP3 protein
CTD
PMID:17240030
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp8
caspase 8
multiple interactions
EXP
1,3-dinitropyrene results in increased cleavage of and results in increased activity of CASP8 protein
CTD
PMID:17240030
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions affects metabolic processing increases expression
ISO EXP
[CYP1A1 protein co-treated with POR protein] results in decreased metabolism of 1,3-dinitropyrene CYP1A1 protein affects the metabolism of 1,3-dinitropyrene 1,3-dinitropyrene results in increased expression of CYP1A1 protein 1,3-dinitropyrene results in increased expression of CYP1A1 mRNA
CTD
PMID:2180560 PMID:11113705 PMID:12107646 PMID:17240030
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions affects metabolic processing
ISO
[CYP1A2 protein co-treated with POR protein] results in decreased metabolism of 1,3-dinitropyrene CYP1A2 protein affects the metabolism of 1,3-dinitropyrene
CTD
PMID:2180560 PMID:11113705
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
multiple interactions
ISO
[CYP1B1 protein co-treated with POR protein] results in decreased metabolism of 1,3-dinitropyrene
CTD
PMID:11113705
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
G
Mapk8
mitogen-activated protein kinase 8
increases phosphorylation
EXP
1,3-dinitropyrene results in increased phosphorylation of MAPK8 protein
CTD
PMID:17240030
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
affects response to substance increases reduction
ISO
NQO1 protein affects the susceptibility to 1,3-dinitropyrene NQO1 protein results in increased reduction of 1,3-dinitropyrene
CTD
PMID:1774770
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Por
cytochrome p450 oxidoreductase
multiple interactions
ISO
[CYP1A1 protein co-treated with POR protein] results in decreased metabolism of 1,3-dinitropyrene; [CYP1A2 protein co-treated with POR protein] results in decreased metabolism of 1,3-dinitropyrene; [CYP1B1 protein co-treated with POR protein] results in decreased metabolism of 1,3-dinitropyrene
CTD
PMID:11113705
NCBI chr 5:135,698,894...135,764,180
Ensembl chr 5:135,698,887...135,764,180
G
Trp53
transformation related protein 53
increases phosphorylation affects localization
EXP
1,3-dinitropyrene results in increased phosphorylation of TRP53 protein 1,3-dinitropyrene affects the localization of TRP53 protein
CTD
PMID:17240030
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
affects metabolic processing increases expression
ISO
CYP1A1 protein affects the metabolism of 1,6-dinitropyrene 1,6-dinitropyrene results in increased expression of CYP1A1 mRNA
CTD
PMID:2180560 PMID:12107646
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
affects metabolic processing
ISO
CYP1A2 protein affects the metabolism of 1,6-dinitropyrene
CTD
PMID:2180560
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
increases response to substance increases reduction
ISO
NQO1 protein results in increased susceptibility to 1,6-dinitropyrene NQO1 protein results in increased reduction of 1,6-dinitropyrene
CTD
PMID:1774770
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Akr1c18
aldo-keto reductase family 1, member C18
multiple interactions
ISO
[AKR1C3 protein results in increased degradation of 1,8-dinitropyrene] which results in increased abundance of 1-amino-8-nitropyrene
CTD
PMID:36399404
NCBI chr13:4,182,614...4,200,645
Ensembl chr13:4,182,614...4,200,653
G
Akr1c20
aldo-keto reductase family 1, member C20
multiple interactions
ISO
[AKR1C1 protein results in increased degradation of 1,8-dinitropyrene] which results in increased abundance of 1-amino-8-nitropyrene
CTD
PMID:36399404
NCBI chr13:4,536,855...4,573,353
Ensembl chr13:4,536,848...4,573,344
G
Akt1
thymoma viral proto-oncogene 1
multiple interactions
EXP
1,8-dinitropyrene results in increased phosphorylation of and results in increased activity of AKT1 protein
CTD
PMID:17240030
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
Bid
BH3 interacting domain death agonist
increases expression
EXP
1,8-dinitropyrene results in increased expression of BID protein
CTD
PMID:17240030
NCBI chr 6:120,870,080...120,894,074
Ensembl chr 6:120,868,891...120,893,814
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions increases expression affects metabolic processing
ISO EXP
[CYP1A1 protein co-treated with POR protein] results in increased metabolism of 1,8-dinitropyrene 1,8-dinitropyrene results in increased expression of CYP1A1 protein 1,8-dinitropyrene results in increased expression of CYP1A1 mRNA CYP1A1 protein affects the metabolism of 1,8-dinitropyrene
CTD
PMID:2180560 PMID:11113705 PMID:12107646 PMID:17240030
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
affects metabolic processing
ISO
CYP1A2 protein affects the metabolism of 1,8-dinitropyrene
CTD
PMID:2180560
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression multiple interactions
ISO
1,8-dinitropyrene results in increased expression of CYP1B1 mRNA [CYP1B1 protein co-treated with POR protein] results in increased metabolism of 1,8-dinitropyrene
CTD
PMID:11113705 PMID:21887816
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
G
Ereg
epiregulin
increases expression
ISO
1,8-dinitropyrene results in increased expression of EREG mRNA
CTD
PMID:21887816
NCBI chr 5:91,222,476...91,241,508
Ensembl chr 5:91,222,481...91,241,505
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
increases response to substance increases reduction
ISO
NQO1 protein results in increased susceptibility to 1,8-dinitropyrene NQO1 protein results in increased reduction of 1,8-dinitropyrene
CTD
PMID:1774770
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Por
cytochrome p450 oxidoreductase
multiple interactions
ISO
[CYP1A1 protein co-treated with POR protein] results in increased metabolism of 1,8-dinitropyrene; [CYP1B1 protein co-treated with POR protein] results in increased metabolism of 1,8-dinitropyrene
CTD
PMID:11113705
NCBI chr 5:135,698,894...135,764,180
Ensembl chr 5:135,698,887...135,764,180
G
Tiparp
TCDD-inducible poly(ADP-ribose) polymerase
increases expression
ISO
1,8-dinitropyrene results in increased expression of TIPARP mRNA
CTD
PMID:21887816
NCBI chr 3:65,435,868...65,462,939
Ensembl chr 3:65,435,831...65,462,939
G
Trp53
transformation related protein 53
increases phosphorylation
EXP
1,8-dinitropyrene results in increased phosphorylation of TRP53 protein
CTD
PMID:17240030
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Ahr
aryl-hydrocarbon receptor
multiple interactions
ISO
1-aminopyrene binds to and results in increased activity of AHR protein
CTD
PMID:28186253
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
G
Akr1c18
aldo-keto reductase family 1, member C18
multiple interactions
ISO
[AKR1C3 protein results in increased degradation of 1-nitropyrene] which results in increased abundance of 1-aminopyrene
CTD
PMID:36399404
NCBI chr13:4,182,614...4,200,645
Ensembl chr13:4,182,614...4,200,653
G
Akr1c20
aldo-keto reductase family 1, member C20
multiple interactions
ISO
[AKR1C1 protein results in increased degradation of 1-nitropyrene] which results in increased abundance of 1-aminopyrene
CTD
PMID:36399404
NCBI chr13:4,536,855...4,573,353
Ensembl chr13:4,536,848...4,573,344
G
Ar
androgen receptor
multiple interactions
ISO
1-aminopyrene inhibits the reaction [Metribolone results in increased activity of AR protein]
CTD
PMID:18324785
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
G
Ccl5
C-C motif chemokine ligand 5
increases expression
ISO
1-aminopyrene results in increased expression of CCL5 mRNA
CTD
PMID:19879285
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
Cxcl15
C-X-C motif chemokine ligand 15
increases secretion
ISO
1-aminopyrene results in increased secretion of CXCL8 protein
CTD
PMID:19879285 PMID:23458896
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases activity
ISO
CYP1A2 protein results in increased activity of 1-aminopyrene
CTD
PMID:15728263
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression
ISO
1-aminopyrene results in increased expression of CYP1B1 mRNA
CTD
PMID:12107646
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
G
Il5
interleukin 5
increases secretion
ISO
1-aminopyrene results in increased secretion of IL5 protein
CTD
PMID:19879285
NCBI chr11:53,611,621...53,615,930
Ensembl chr11:53,611,621...53,615,933
G
Tlr3
toll-like receptor 3
multiple interactions
ISO
[Poly I-C binds to TLR3 protein] which affects the susceptibility to 1-aminopyrene
CTD
PMID:23458896
NCBI chr 8:45,848,702...45,864,112
Ensembl chr 8:45,848,702...45,864,117
G
Abcg2
ATP binding cassette subfamily G member 2 (Junior blood group)
increases secretion multiple interactions
ISO
ABCG2 protein results in increased secretion of 1-hydroxypyrene metabolite 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester inhibits the reaction [ABCG2 protein results in increased secretion of 1-hydroxypyrene metabolite]
CTD
PMID:24140465
NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
G
Aifm3
apoptosis-inducing factor, mitochondrion-associated 3
decreases expression
ISO
1-hydroxypyrene results in decreased expression of AIFM3 mRNA
CTD
PMID:21854004
NCBI chr16:17,307,418...17,325,349
Ensembl chr16:17,307,475...17,325,349
G
Ar
androgen receptor
multiple interactions
ISO
1-hydroxypyrene binds to and results in decreased activity of AR protein; 1-hydroxypyrene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 1-hydroxypyrene inhibits the reaction [Metribolone results in increased activity of AR protein]
CTD
PMID:18324785 PMID:27436773 PMID:33049310
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
G
Arfgap2
ADP-ribosylation factor GTPase activating protein 2
decreases expression
ISO
1-hydroxypyrene results in decreased expression of ARFGAP2 mRNA
CTD
PMID:21854004
NCBI chr 2:91,095,460...91,107,716
Ensembl chr 2:91,095,319...91,107,276
G
Asxl2
ASXL transcriptional regulator 2
decreases expression
ISO
1-hydroxypyrene results in decreased expression of ASXL2 mRNA
CTD
PMID:21854004
NCBI chr12:3,476,892...3,560,811
Ensembl chr12:3,476,857...3,556,852
G
C3
complement component 3
increases expression
ISO
1-hydroxypyrene results in increased expression of C3 mRNA
CTD
PMID:22989670
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
Cldn15
claudin 15
decreases expression
ISO
1-hydroxypyrene results in decreased expression of CLDN15 mRNA
CTD
PMID:21854004
NCBI chr 5:136,996,723...137,004,699
Ensembl chr 5:136,995,470...137,004,712
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases secretion
ISO
CYP1A1 gene polymorphism results in decreased secretion of 1-hydroxypyrene
CTD
PMID:21787681
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Dazap1
DAZ associated protein 1
decreases expression
ISO
1-hydroxypyrene results in decreased expression of DAZAP1 mRNA
CTD
PMID:21854004
NCBI chr10:80,097,168...80,124,242
Ensembl chr10:80,097,320...80,124,242
G
E4f1
E4F transcription factor 1
decreases expression
ISO
1-hydroxypyrene results in decreased expression of E4F1 mRNA
CTD
PMID:21854004
NCBI chr17:24,662,752...24,674,366
Ensembl chr17:24,662,752...24,689,287
G
Erp27
endoplasmic reticulum protein 27
decreases expression
ISO
1-hydroxypyrene results in decreased expression of ERP27 mRNA
CTD
PMID:21854004
NCBI chr 6:136,884,312...136,899,465
Ensembl chr 6:136,884,309...136,899,178
G
Esr1
estrogen receptor 1 (alpha)
multiple interactions
ISO
1-hydroxypyrene binds to and results in increased activity of ESR1 protein
CTD
PMID:33049310
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Esr2
estrogen receptor 2 (beta)
multiple interactions affects binding
ISO
1-hydroxypyrene binds to and results in increased activity of ESR2 protein; 1-hydroxypyrene inhibits the reaction [ESR2 protein binds to Estradiol] ESR2 protein binds to 1-hydroxypyrene
CTD
PMID:22989670 PMID:33049310
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
G
Faap100
Fanconi anemia core complex associated protein 100
decreases expression
ISO
1-hydroxypyrene results in decreased expression of FAAP100 mRNA
CTD
PMID:21854004
NCBI chr11:120,260,388...120,269,572
Ensembl chr11:120,259,881...120,269,590
G
Foxp3
forkhead box P3
multiple interactions
ISO
[Polycyclic Aromatic Hydrocarbons results in increased abundance of 1-hydroxypyrene] which results in decreased expression of FOXP3 mRNA
CTD
PMID:30951957
NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484
G
Fst
follistatin
multiple interactions
ISO
[Polycyclic Aromatic Hydrocarbons results in increased abundance of 1-hydroxypyrene] which results in increased expression of FST protein
CTD
PMID:31228248
NCBI chr13:114,588,798...114,595,522
Ensembl chr13:114,588,826...114,595,487
G
Gimap6
GTPase, IMAP family member 6
increases expression
ISO
1-hydroxypyrene results in increased expression of GIMAP6 mRNA
CTD
PMID:21854004
NCBI chr 6:48,678,517...48,685,178
Ensembl chr 6:48,678,516...48,685,159
G
Gm34066
predicted gene, 34066
decreases expression
ISO
1-hydroxypyrene results in decreased expression of C2ORF66 mRNA
CTD
PMID:21854004
NCBI chr 1:54,481,731...54,495,945
Ensembl chr 1:54,482,563...54,495,922
G
Gstm1
glutathione S-transferase, mu 1
decreases secretion
ISO
GSTM1 gene polymorphism results in decreased secretion of 1-hydroxypyrene
CTD
PMID:21787681
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Gstp1
glutathione S-transferase, pi 1
decreases secretion
ISO
GSTP1 gene polymorphism results in decreased secretion of 1-hydroxypyrene
CTD
PMID:21787681
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
G
Haghl
hydroxyacylglutathione hydrolase-like
decreases expression
ISO
1-hydroxypyrene results in decreased expression of HAGHL mRNA
CTD
PMID:21854004
NCBI chr17:25,998,817...26,004,560
Ensembl chr17:25,998,817...26,004,647
G
Hspb1
heat shock protein 1
multiple interactions
ISO
[Polycyclic Aromatic Hydrocarbons results in increased abundance of 1-hydroxypyrene] which results in increased expression of HSPB1 protein
CTD
PMID:31228248
NCBI chr 5:135,916,773...135,918,417
Ensembl chr 5:135,916,773...135,918,417
G
Il16
interleukin 16
multiple interactions
ISO
[Polycyclic Aromatic Hydrocarbons results in increased abundance of 1-hydroxypyrene] which results in increased expression of IL16 protein
CTD
PMID:31228248
NCBI chr 7:83,292,027...83,395,479
Ensembl chr 7:83,292,033...83,394,934
G
Itsn2
intersectin 2
increases expression
ISO
1-hydroxypyrene results in increased expression of ITSN2 mRNA
CTD
PMID:21854004
NCBI chr12:4,642,792...4,763,952
Ensembl chr12:4,642,638...4,763,962
G
Jag1
jagged 1
decreases expression
ISO
1-hydroxypyrene results in decreased expression of JAG1 mRNA
CTD
PMID:22989670
NCBI chr 2:136,923,371...136,958,440
Ensembl chr 2:136,923,376...136,958,564
G
Lrp12
low density lipoprotein-related protein 12
decreases expression
ISO
1-hydroxypyrene results in decreased expression of LRP12 mRNA
CTD
PMID:21854004
NCBI chr15:39,733,985...39,807,417
Ensembl chr15:39,733,985...39,807,390
G
Myo15b
myosin XVB
decreases expression
ISO
1-hydroxypyrene results in decreased expression of MYO15B mRNA
CTD
PMID:21854004
NCBI chr11:115,749,002...115,783,443
Ensembl chr11:115,749,232...115,783,429
G
Nipal4
NIPA-like domain containing 4
increases expression
ISO
1-hydroxypyrene results in increased expression of NIPAL4 mRNA
CTD
PMID:21854004
NCBI chr11:46,038,982...46,057,186
Ensembl chr11:46,038,982...46,057,335
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO EXP
1-hydroxypyrene binds to and results in increased activity of NR1I2 protein
CTD
PMID:33049310
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
increases activity
ISO
1-hydroxypyrene results in increased activity of NR1I3 protein
CTD
PMID:28927721
NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270
G
Nrip1
nuclear receptor interacting protein 1
increases expression
ISO
1-hydroxypyrene results in increased expression of NRIP1 mRNA
CTD
PMID:22989670
NCBI chr16:76,084,291...76,170,930
Ensembl chr16:76,084,288...76,170,715
G
Pgr
progesterone receptor
multiple interactions
ISO
1-hydroxypyrene inhibits the reaction [Progesterone binds to PGR protein]; [Progesterone co-treated with 1-hydroxypyrene] results in decreased expression of PGR mRNA
CTD
PMID:9144411
NCBI chr 9:8,890,017...8,968,612
Ensembl chr 9:8,899,834...8,968,612
G
Phf2
PHD finger protein 2
increases expression
ISO
1-hydroxypyrene results in increased expression of PHF2 mRNA
CTD
PMID:21854004
NCBI chr13:48,955,226...49,024,361
Ensembl chr13:48,955,226...49,024,595
G
Pparg
peroxisome proliferator activated receptor gamma
multiple interactions
ISO EXP
1-hydroxypyrene binds to and results in increased activity of PPARG protein
CTD
PMID:33049310
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Ptgr1
prostaglandin reductase 1
increases expression
ISO
1-hydroxypyrene results in increased expression of PTGR1 mRNA
CTD
PMID:21854004
NCBI chr 4:58,965,590...58,987,131
Ensembl chr 4:58,965,439...58,987,119
G
Slc12a7
solute carrier family 12, member 7
decreases expression
ISO
1-hydroxypyrene results in decreased expression of SLC12A7 mRNA
CTD
PMID:21854004
NCBI chr13:73,881,172...73,964,873
Ensembl chr13:73,881,213...73,964,873
G
Slc25a34
solute carrier family 25, member 34
decreases expression
ISO
1-hydroxypyrene results in decreased expression of SLC25A34 mRNA
CTD
PMID:21854004
NCBI chr 4:141,346,130...141,351,202
Ensembl chr 4:141,346,135...141,351,132
G
Spns3
SPNS lysolipid transporter 3, sphingosine-1-phosphate (putative)
decreases expression
ISO
1-hydroxypyrene results in decreased expression of SPNS3 mRNA
CTD
PMID:21854004
NCBI chr11:72,388,979...72,441,334
Ensembl chr11:72,385,745...72,441,332
G
Sult1a1
sulfotransferase family 1A, phenol-preferring, member 1
increases metabolic processing
ISO
SULT1A2 protein results in increased metabolism of 1-hydroxypyrene
CTD
PMID:24140465
NCBI chr 7:126,272,042...126,289,615
Ensembl chr 7:126,272,037...126,275,604
G
Sult1b1
sulfotransferase family 1B, member 1
increases metabolic processing
ISO
SULT1B1 protein results in increased metabolism of 1-hydroxypyrene
CTD
PMID:24140465
NCBI chr 5:87,661,186...87,686,054
Ensembl chr 5:87,661,198...87,686,054
G
Sult1e1
sulfotransferase family 1E, member 1
decreases activity increases sulfation multiple interactions
ISO
1-hydroxypyrene results in decreased activity of SULT1E1 protein SULT1E1 protein results in increased sulfation of 1-hydroxypyrene acetonitrile promotes the reaction [SULT1E1 protein results in increased sulfation of 1-hydroxypyrene]; Ethanol inhibits the reaction [SULT1E1 protein results in increased sulfation of 1-hydroxypyrene]; Ethanol promotes the reaction [1-hydroxypyrene results in decreased activity of SULT1E1 protein]
CTD
PMID:14570759 PMID:16914110
NCBI chr 5:87,723,827...87,739,470
Ensembl chr 5:87,723,828...87,739,453
G
Sult2a1
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 1
multiple interactions
ISO
Dimethylformamide inhibits the reaction [SULT2A1 protein results in increased sulfation of 1-hydroxypyrene]; Ethanol inhibits the reaction [SULT2A1 protein results in increased sulfation of 1-hydroxypyrene]; Ethanol promotes the reaction [1-hydroxypyrene results in decreased activity of SULT2A1 protein]
CTD
PMID:14570759
NCBI chr 7:13,530,171...13,571,335
Ensembl chr 7:13,530,171...13,571,334
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
[Polycyclic Aromatic Hydrocarbons results in increased abundance of 1-hydroxypyrene] which results in decreased expression of TGFB1 mRNA
CTD
PMID:30951957
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Thra
thyroid hormone receptor alpha
multiple interactions
ISO
1-hydroxypyrene binds to and results in increased activity of THRA protein
CTD
PMID:33049310
NCBI chr11:98,631,539...98,659,832
Ensembl chr11:98,631,464...98,659,832
G
Tmem234
transmembrane protein 234
decreases expression
ISO
1-hydroxypyrene results in decreased expression of TMEM234 mRNA
CTD
PMID:21854004
NCBI chr 4:129,494,449...129,502,326
Ensembl chr 4:129,494,461...129,517,852
G
Ugt1a1
UDP glucuronosyltransferase 1 family, polypeptide A1
increases glucuronidation
ISO
UGT1A1 protein results in increased glucuronidation of 1-hydroxypyrene
CTD
PMID:15802387
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
G
Ugt1a10
UDP glycosyltransferase 1 family, polypeptide A10
increases glucuronidation
ISO
UGT1A10 protein results in increased glucuronidation of 1-hydroxypyrene
CTD
PMID:15802387
NCBI chr 1:87,983,133...88,147,724
Ensembl chr 1:87,983,110...88,146,726
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases glucuronidation
ISO
UGT1A3 protein results in increased glucuronidation of 1-hydroxypyrene
CTD
PMID:15802387
NCBI chr 1:88,128,333...88,147,724
Ensembl chr 1:88,128,323...88,146,719
G
Ugt1a5
UDP glucuronosyltransferase 1 family, polypeptide A5
increases glucuronidation
ISO
UGT1A4 protein results in increased glucuronidation of 1-hydroxypyrene
CTD
PMID:15802387
NCBI chr 1:88,093,734...88,147,724
Ensembl chr 1:88,093,734...88,146,719
G
Ugt1a6b
UDP glucuronosyltransferase 1 family, polypeptide A6B
increases glucuronidation
ISO
UGT1A6 protein results in increased glucuronidation of 1-hydroxypyrene
CTD
PMID:15802387
NCBI chr 1:88,030,979...88,146,720
Ensembl chr 1:88,030,974...88,146,725
G
Ugt1a9
UDP glucuronosyltransferase 1 family, polypeptide A9
increases glucuronidation
ISO
UGT1A9 protein results in increased glucuronidation of 1-hydroxypyrene
CTD
PMID:15802387
NCBI chr 1:87,998,501...88,147,724
Ensembl chr 1:87,998,522...88,146,719
G
Ugt2a1
UDP glucuronosyltransferase 2 family, polypeptide A1
increases glucuronidation
ISO
UGT2A1 protein results in increased glucuronidation of 1-hydroxypyrene
CTD
PMID:21164388
NCBI chr 5:87,607,349...87,638,730
Ensembl chr 5:87,607,349...87,638,730
G
Vmn1r237
vomeronasal 1 receptor 237
decreases expression
ISO
1-hydroxypyrene results in decreased expression of VN1R4 mRNA
CTD
PMID:21854004
NCBI chr17:21,534,279...21,535,148
Ensembl chr17:21,532,127...21,535,174
G
Zfp335
zinc finger protein 335
decreases expression
ISO
1-hydroxypyrene results in decreased expression of ZNF335 mRNA
CTD
PMID:21854004
NCBI chr 2:164,733,802...164,756,034
Ensembl chr 2:164,733,802...164,753,677
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
ISO
[CYP1A2 protein co-treated with SULT1A1 protein] results in increased susceptibility to 1-methylpyrene
CTD
PMID:33035519
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
ISO
1-aminobenzotriazole inhibits the reaction [[[SULT1A1 protein co-treated with CYP2E1 protein] results in increased susceptibility to 1-methylpyrene] which results in increased mutagenesis of HPRT1 gene]; [[SULT1A1 protein co-treated with CYP2E1 protein] results in increased susceptibility to 1-methylpyrene] which results in increased mutagenesis of HPRT1 gene; [SULT1A1 protein co-treated with CYP2E1 protein] results in increased susceptibility to 1-methylpyrene; Pentachlorophenol inhibits the reaction [[[SULT1A1 protein co-treated with CYP2E1 protein] results in increased susceptibility to 1-methylpyrene] which results in increased mutagenesis of HPRT1 gene]
CTD
PMID:25243916 PMID:27913846
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
multiple interactions
ISO
1-aminobenzotriazole inhibits the reaction [[[SULT1A1 protein co-treated with CYP2E1 protein] results in increased susceptibility to 1-methylpyrene] which results in increased mutagenesis of HPRT1 gene]; [[SULT1A1 protein co-treated with CYP2E1 protein] results in increased susceptibility to 1-methylpyrene] which results in increased mutagenesis of HPRT1 gene; Pentachlorophenol inhibits the reaction [[[SULT1A1 protein co-treated with CYP2E1 protein] results in increased susceptibility to 1-methylpyrene] which results in increased mutagenesis of HPRT1 gene]
CTD
PMID:25243916
NCBI chr X:52,076,955...52,110,537
Ensembl chr X:52,077,014...52,110,536
G
Tnf
tumor necrosis factor
multiple interactions
EXP
[Particulate Matter results in increased abundance of 4-nitropyrene] which results in increased secretion of TNF protein
CTD
PMID:32007923
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Abcc4
ATP-binding cassette, sub-family C member 4
multiple interactions increases expression increases export
ISO
[ABCC4 protein results in increased export of benzo(a)pyrene 7,8-dihydrodiol] which results in decreased chemical synthesis of benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide-DNA benzo(a)pyrene 7,8-dihydrodiol results in increased expression of ABCC4 mRNA; benzo(a)pyrene 7,8-dihydrodiol results in increased expression of ABCC4 protein
CTD
PMID:22155354
NCBI chr14:118,720,104...118,945,475
Ensembl chr14:118,720,104...118,943,631
G
Akr1a1
aldo-keto reductase family 1, member A1
multiple interactions decreases response to substance
ISO
[AKR1A1 protein co-treated with NADP] results in increased oxidation of and affects the activity of benzo(a)pyrene 7,8-dihydrodiol; AKR1A1 protein affects the metabolism of and results in increased activity of benzo(a)pyrene 7,8-dihydrodiol; NAD promotes the reaction [AKR1A1 protein affects the metabolism of and results in increased activity of benzo(a)pyrene 7,8-dihydrodiol]; NADP promotes the reaction [AKR1A1 protein affects the metabolism of and results in increased activity of benzo(a)pyrene 7,8-dihydrodiol]; ponalrestat inhibits the reaction [AKR1A1 protein results in decreased susceptibility to benzo(a)pyrene 7,8-dihydrodiol]
CTD
PMID:15720144 PMID:21910479 PMID:22053912
NCBI chr 4:116,493,707...116,508,871
Ensembl chr 4:116,493,707...116,508,877
G
Akr1b1
aldo-keto reductase family 1 member B
multiple interactions
ISO
[AKR1B1 protein co-treated with NADP] results in increased oxidation of and affects the activity of benzo(a)pyrene 7,8-dihydrodiol
CTD
PMID:21910479
NCBI chr 6:34,280,865...34,294,424
Ensembl chr 6:34,279,369...34,294,413
G
Akr1b10
aldo-keto reductase family 1, member B10
multiple interactions
ISO
[AKR1B10 protein co-treated with NADP] results in increased oxidation of and affects the activity of benzo(a)pyrene 7,8-dihydrodiol
CTD
PMID:21910479
NCBI chr 6:34,361,182...34,373,884
Ensembl chr 6:34,361,153...34,373,885
G
Akr1c18
aldo-keto reductase family 1, member C18
multiple interactions
ISO
[AKR1C3 protein co-treated with NADP] results in increased oxidation of and affects the activity of benzo(a)pyrene 7,8-dihydrodiol
CTD
PMID:21910479
NCBI chr13:4,182,614...4,200,645
Ensembl chr13:4,182,614...4,200,653
G
Akr1c20
aldo-keto reductase family 1, member C20
multiple interactions
ISO
[AKR1C1 protein co-treated with NADP] results in increased oxidation of and affects the activity of benzo(a)pyrene 7,8-dihydrodiol
CTD
PMID:21910479
NCBI chr13:4,536,855...4,573,353
Ensembl chr13:4,536,848...4,573,344
G
Akr1c21
aldo-keto reductase family 1, member C21
multiple interactions
ISO
[AKR1C2 protein co-treated with NADP] results in increased oxidation of and affects the activity of benzo(a)pyrene 7,8-dihydrodiol
CTD
PMID:21910479
NCBI chr13:4,624,074...4,636,542
Ensembl chr13:4,624,074...4,636,540
G
Akr1c6
aldo-keto reductase family 1, member C6
multiple interactions
ISO
[AKR1C4 protein co-treated with NADP] results in increased oxidation of and affects the activity of benzo(a)pyrene 7,8-dihydrodiol
CTD
PMID:21910479
NCBI chr13:4,484,354...4,507,529
Ensembl chr13:4,484,305...4,507,876
G
Bad
BCL2-associated agonist of cell death
decreases expression increases phosphorylation
ISO
benzo(a)pyrene 7,8-dihydrodiol results in decreased expression of BAD protein benzo(a)pyrene 7,8-dihydrodiol results in increased phosphorylation of BAD protein
CTD
PMID:15698582
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
G
Bcl2l1
BCL2-like 1
decreases expression
ISO
benzo(a)pyrene 7,8-dihydrodiol results in decreased expression of BCL2L1 protein
CTD
PMID:15698582
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
G
Bid
BH3 interacting domain death agonist
decreases expression
ISO
benzo(a)pyrene 7,8-dihydrodiol results in decreased expression of BID protein
CTD
PMID:15698582
NCBI chr 6:120,870,080...120,894,074
Ensembl chr 6:120,868,891...120,893,814
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression multiple interactions increases chemical synthesis
ISO EXP
benzo(a)pyrene 7,8-dihydrodiol results in increased expression of CYP1A1 mRNA [CYP1A1 protein results in increased metabolism of Benzo(a)pyrene] which results in increased abundance of benzo(a)pyrene 7,8-dihydrodiol [[CYP1A1 protein co-treated with POR protein co-treated with EPHX1 protein] results in increased oxidation of Benzo(a)pyrene] which results in increased abundance of benzo(a)pyrene 7,8-dihydrodiol [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA] which results in increased secretion of benzo(a)pyrene 7,8-dihydrodiol; benzo(a)pyrene 7,8-dihydrodiol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; CYP1A1 protein affects the metabolism of and results in increased activity of benzo(a)pyrene 7,8-dihydrodiol; CYP1A1 protein promotes the reaction [benzo(a)pyrene 7,8-dihydrodiol results in increased mutagenesis of HPRT1 gene]; GSTM1 protein inhibits the reaction [CYP1A1 protein promotes the reaction [benzo(a)pyrene 7,8-dihydrodiol results in increased mutagenesis of HPRT1 gene]]; hyperforin inhibits the reaction [CYP1A1 protein affects the metabolism of benzo(a)pyrene 7,8-dihydrodiol]; hypericin inhibits the reaction [CYP1A1 protein affects the metabolism of benzo(a)pyrene 7,8-dihydrodiol]; Medroxyprogesterone Acetate inhibits the reaction [benzo(a)pyrene 7,8-dihydrodiol results in increased expression of CYP1A1 mRNA]; pseudohypericin inhibits the reaction [CYP1A1 protein affects the metabolism of benzo(a)pyrene 7,8-dihydrodiol]; Quercetin inhibits the reaction [CYP1A1 protein affects the metabolism of benzo(a)pyrene 7,8-dihydrodiol]; Ursodeoxycholic Acid inhibits the reaction [benzo(a)pyrene 7,8-dihydrodiol results in increased expression of CYP1A1 mRNA] CYP1A1 protein results in increased chemical synthesis of benzo(a)pyrene 7,8-dihydrodiol
CTD
PMID:2154339 PMID:10706104 PMID:14633740 PMID:15720144 PMID:17525473 PMID:19879933 PMID:21028851 PMID:24530354 PMID:32227843 More...
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression affects metabolic processing increases chemical synthesis increases oxidation multiple interactions
ISO
benzo(a)pyrene 7,8-dihydrodiol results in increased expression of CYP1B1 mRNA CYP1B1 affects the metabolism of benzo(a)pyrene 7,8-dihydrodiol CYP1B1 protein results in increased chemical synthesis of benzo(a)pyrene 7,8-dihydrodiol CYP1B1 protein results in increased oxidation of benzo(a)pyrene 7,8-dihydrodiol benzo(a)pyrene 7,8-dihydrodiol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]; bergamottin inhibits the reaction [CYP1B1 protein results in increased oxidation of benzo(a)pyrene 7,8-dihydrodiol]; CYP1B1 protein affects the metabolism of and results in increased activity of benzo(a)pyrene 7,8-dihydrodiol; imperatorin inhibits the reaction [CYP1B1 protein results in increased oxidation of benzo(a)pyrene 7,8-dihydrodiol]; isoimperatorin inhibits the reaction [CYP1B1 protein results in increased oxidation of benzo(a)pyrene 7,8-dihydrodiol]; isopimpinellin inhibits the reaction [CYP1B1 protein results in increased oxidation of benzo(a)pyrene 7,8-dihydrodiol]; NADP promotes the reaction [CYP1B1 protein affects the metabolism of and results in increased activity of benzo(a)pyrene 7,8-dihydrodiol]
CTD
PMID:15720144 PMID:15861043 PMID:19879933 PMID:21028851 PMID:24025706
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
G
Cyp2s1
cytochrome P450, family 2, subfamily s, polypeptide 1
multiple interactions
ISO
[[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of benzo(a)pyrene 7,8-dihydrodiol] which results in increased abundance of benzo(a)pyrene-7,8,9,10-tetrol; [[CYP2S1 protein co-treated with Hydrogen Peroxide] results in increased oxidation of benzo(a)pyrene 7,8-dihydrodiol] which results in increased abundance of benzo(a)pyrene-7,8,9,10-tetrol; [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of benzo(a)pyrene 7,8-dihydrodiol
CTD
PMID:19713358
NCBI chr 7:25,501,894...25,515,950
Ensembl chr 7:25,501,900...25,516,338
G
Ephx1
epoxide hydrolase 1, microsomal
multiple interactions
ISO
[[CYP1A1 protein co-treated with POR protein co-treated with EPHX1 protein] results in increased oxidation of Benzo(a)pyrene] which results in increased abundance of benzo(a)pyrene 7,8-dihydrodiol
CTD
PMID:24530354
NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
G
Gstm1
glutathione S-transferase, mu 1
multiple interactions
ISO
GSTM1 protein inhibits the reaction [CYP1A1 protein promotes the reaction [benzo(a)pyrene 7,8-dihydrodiol results in increased mutagenesis of HPRT1 gene]]
CTD
PMID:17525473
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
multiple interactions
ISO
CYP1A1 protein promotes the reaction [benzo(a)pyrene 7,8-dihydrodiol results in increased mutagenesis of HPRT1 gene]; GSTM1 protein inhibits the reaction [CYP1A1 protein promotes the reaction [benzo(a)pyrene 7,8-dihydrodiol results in increased mutagenesis of HPRT1 gene]]
CTD
PMID:17525473
NCBI chr X:52,076,955...52,110,537
Ensembl chr X:52,077,014...52,110,536
G
Hras
Harvey rat sarcoma virus oncogene
increases expression
ISO
benzo(a)pyrene 7,8-dihydrodiol results in increased expression of HRAS mRNA
CTD
PMID:11008122
NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918
G
Mapk14
mitogen-activated protein kinase 14
increases phosphorylation
ISO
benzo(a)pyrene 7,8-dihydrodiol results in increased phosphorylation of MAPK14 protein
CTD
PMID:15698582
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
G
Mapk8
mitogen-activated protein kinase 8
increases phosphorylation
ISO
benzo(a)pyrene 7,8-dihydrodiol results in increased phosphorylation of MAPK8 protein
CTD
PMID:15698582 PMID:22053912
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
increases expression
ISO
benzo(a)pyrene 7,8-dihydrodiol results in increased expression of NQO1 mRNA
CTD
PMID:11008122
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
[benzo(a)pyrene 7,8-dihydrodiol binds to and results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; benzo(a)pyrene 7,8-dihydrodiol binds to and results in increased activity of NR1I2 protein
CTD
PMID:23845848
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
G
Parp1
poly (ADP-ribose) polymerase family, member 1
multiple interactions increases cleavage
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [benzo(a)pyrene 7,8-dihydrodiol results in increased cleavage of PARP1 protein]
CTD
PMID:15572374
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Por
cytochrome p450 oxidoreductase
multiple interactions
ISO
[[CYP1A1 protein co-treated with POR protein co-treated with EPHX1 protein] results in increased oxidation of Benzo(a)pyrene] which results in increased abundance of benzo(a)pyrene 7,8-dihydrodiol
CTD
PMID:24530354
NCBI chr 5:135,698,894...135,764,180
Ensembl chr 5:135,698,887...135,764,180
G
Ptgs1
prostaglandin-endoperoxide synthase 1
increases metabolic processing
ISO
PTGS1 protein results in increased metabolism of benzo(a)pyrene 7,8-dihydrodiol
CTD
PMID:11159734
NCBI chr 2:36,106,758...36,142,287
Ensembl chr 2:36,120,438...36,142,284
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases metabolic processing
ISO
PTGS2 protein results in increased metabolism of benzo(a)pyrene 7,8-dihydrodiol
CTD
PMID:11159734
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Tnf
tumor necrosis factor
multiple interactions
ISO
TNF protein inhibits the reaction [Benzo(a)pyrene results in increased abundance of benzo(a)pyrene 7,8-dihydrodiol]
CTD
PMID:24025706
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Trp53
transformation related protein 53
multiple interactions increases chemical synthesis
ISO
[TP53 protein results in increased susceptibility to Etoposide] which results in decreased chemical synthesis of benzo(a)pyrene 7,8-dihydrodiol; benzo(a)pyrene 7,8-dihydrodiol results in increased expression of and results in increased phosphorylation of TP53 protein; Etoposide promotes the reaction [TP53 protein results in increased chemical synthesis of benzo(a)pyrene 7,8-dihydrodiol]
CTD
PMID:15698582 PMID:29471073
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Ugt2a1
UDP glucuronosyltransferase 2 family, polypeptide A1
increases glucuronidation
ISO
UGT2A1 protein results in increased glucuronidation of benzo(a)pyrene 7,8-dihydrodiol
CTD
PMID:21164388
NCBI chr 5:87,607,349...87,638,730
Ensembl chr 5:87,607,349...87,638,730
G
Ahr
aryl-hydrocarbon receptor
affects localization multiple interactions
ISO EXP
benzo(a)pyrene-7,8-dione affects the localization of AHR protein AHR protein affects the reaction [benzo(a)pyrene-7,8-dione results in increased expression of CYP1A1 mRNA]
CTD
PMID:10706104
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
G
Akr1a1
aldo-keto reductase family 1, member A1
increases chemical synthesis multiple interactions affects chemical synthesis increases expression
ISO
AKR1A1 protein results in increased chemical synthesis of benzo(a)pyrene-7,8-dione [AKR1A1 protein co-treated with NADP] results in increased reduction of and affects the activity of benzo(a)pyrene-7,8-dione; AKR1A1 protein results in increased reduction of and affects the activity of benzo(a)pyrene-7,8-dione; NAD promotes the reaction [AKR1A1 protein affects the chemical synthesis of benzo(a)pyrene-7,8-dione] benzo(a)pyrene-7,8-dione results in increased expression of AKR1A1 mRNA
CTD
PMID:9973208 PMID:15720144 PMID:16411658 PMID:21910479
NCBI chr 4:116,493,707...116,508,871
Ensembl chr 4:116,493,707...116,508,877
G
Akr1b1
aldo-keto reductase family 1 member B
multiple interactions
ISO
[AKR1B1 protein co-treated with NADP] results in increased reduction of and affects the activity of benzo(a)pyrene-7,8-dione
CTD
PMID:21910479
NCBI chr 6:34,280,865...34,294,424
Ensembl chr 6:34,279,369...34,294,413
G
Akr1b10
aldo-keto reductase family 1, member B10
multiple interactions
ISO
[AKR1B10 protein co-treated with NADP] results in increased reduction of and affects the activity of benzo(a)pyrene-7,8-dione
CTD
PMID:21910479
NCBI chr 6:34,361,182...34,373,884
Ensembl chr 6:34,361,153...34,373,885
G
Akr1c18
aldo-keto reductase family 1, member C18
multiple interactions
ISO
[AKR1C3 protein co-treated with NADP] results in increased reduction of and affects the activity of benzo(a)pyrene-7,8-dione
CTD
PMID:21910479
NCBI chr13:4,182,614...4,200,645
Ensembl chr13:4,182,614...4,200,653
G
Akr1c20
aldo-keto reductase family 1, member C20
multiple interactions increases expression
ISO
[AKR1C1 protein co-treated with NADP] results in increased reduction of and affects the activity of benzo(a)pyrene-7,8-dione benzo(a)pyrene-7,8-dione results in increased expression of AKR1C1 mRNA
CTD
PMID:9973208 PMID:21910479
NCBI chr13:4,536,855...4,573,353
Ensembl chr13:4,536,848...4,573,344
G
Akr1c21
aldo-keto reductase family 1, member C21
multiple interactions
ISO
[AKR1C2 protein co-treated with NADP] results in increased reduction of and affects the activity of benzo(a)pyrene-7,8-dione
CTD
PMID:21910479
NCBI chr13:4,624,074...4,636,542
Ensembl chr13:4,624,074...4,636,540
G
Akr1c6
aldo-keto reductase family 1, member C6
multiple interactions
ISO
[AKR1C4 protein co-treated with NADP] results in increased reduction of and affects the activity of benzo(a)pyrene-7,8-dione
CTD
PMID:21910479
NCBI chr13:4,484,354...4,507,529
Ensembl chr13:4,484,305...4,507,876
G
Akr7a5
aldo-keto reductase family 7, member A5
multiple interactions
ISO
[[AKR7A2 protein co-treated with NADP] results in increased reduction of and affects the activity of benzo(a)pyrene-7,8-dione] which results in decreased abundance of Oxygen; [[AKR7A2 protein co-treated with NADP] results in increased reduction of and affects the activity of benzo(a)pyrene-7,8-dione] which results in increased chemical synthesis of Hydrogen Peroxide; [[AKR7A2 protein co-treated with NADP] results in increased reduction of and affects the activity of benzo(a)pyrene-7,8-dione] which results in increased chemical synthesis of Superoxides; [AKR7A2 protein co-treated with NADP] results in increased reduction of and affects the activity of benzo(a)pyrene-7,8-dione
CTD
PMID:21910479
NCBI chr 4:139,038,005...139,046,097
Ensembl chr 4:139,038,055...139,045,737
G
Arnt
aryl hydrocarbon receptor nuclear translocator
multiple interactions
EXP
ARNT protein affects the reaction [benzo(a)pyrene-7,8-dione results in increased expression of CYP1A1 mRNA]
CTD
PMID:10706104
NCBI chr 3:95,341,674...95,404,551
Ensembl chr 3:95,341,699...95,404,551
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions increases expression
EXP ISO
AHR protein affects the reaction [benzo(a)pyrene-7,8-dione results in increased expression of CYP1A1 mRNA]; ARNT protein affects the reaction [benzo(a)pyrene-7,8-dione results in increased expression of CYP1A1 mRNA]
CTD
PMID:9973208 PMID:10706104
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
multiple interactions increases expression
ISO
benzo(a)pyrene-7,8-dione results in increased expression of and results in increased activity of CYP1B1 protein benzo(a)pyrene-7,8-dione results in increased expression of CYP1B1 mRNA
CTD
PMID:16411658
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
G
Hmox1
heme oxygenase 1
multiple interactions increases expression
ISO
alpha-Tocopherol inhibits the reaction [benzo(a)pyrene-7,8-dione results in increased expression of HMOX1 protein]; Ascorbic Acid inhibits the reaction [benzo(a)pyrene-7,8-dione results in increased expression of HMOX1 protein] benzo(a)pyrene-7,8-dione results in increased expression of HMOX1 mRNA; benzo(a)pyrene-7,8-dione results in increased expression of HMOX1 protein
CTD
PMID:22053912
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Mapk1
mitogen-activated protein kinase 1
multiple interactions
EXP
benzo(a)pyrene-7,8-dione results in increased phosphorylation of and results in increased activity of MAPK1 protein
CTD
PMID:12213569
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk3
mitogen-activated protein kinase 3
multiple interactions
EXP
benzo(a)pyrene-7,8-dione results in increased phosphorylation of and results in increased activity of MAPK3 protein
CTD
PMID:12213569
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
increases expression multiple interactions
ISO
benzo(a)pyrene-7,8-dione results in increased expression of NQO1 mRNA; benzo(a)pyrene-7,8-dione results in increased expression of NQO1 protein [NQO1 protein co-treated with NADP] results in increased reduction of and affects the activity of benzo(a)pyrene-7,8-dione
CTD
PMID:21910479 PMID:22053912
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Sult1e1
sulfotransferase family 1E, member 1
increases metabolic processing
ISO
SULT1E1 protein results in increased metabolism of benzo(a)pyrene-7,8-dione
CTD
PMID:22782890
NCBI chr 5:87,723,827...87,739,470
Ensembl chr 5:87,723,828...87,739,453
G
Cyp2c52-ps
cytochrome P450, family 2, subfamily c, polypeptide 52, pseudogene
multiple interactions
ISO
CYP2C11 protein promotes the reaction [EPHX1 protein affects the hydrolysis of benzo(a)pyrene 7,8-oxide]
CTD
PMID:12051674
NCBI chr19:38,965,106...38,992,071
Ensembl chr19:38,965,091...38,991,733
G
Ephx1
epoxide hydrolase 1, microsomal
multiple interactions
ISO
CYP2C11 protein promotes the reaction [EPHX1 protein affects the hydrolysis of benzo(a)pyrene 7,8-oxide]
CTD
PMID:12051674
NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
G
Ahr
aryl-hydrocarbon receptor
multiple interactions
ISO
cyclopenta(c,d)pyrene binds to and results in increased activity of AHR protein
CTD
PMID:11525907
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
G
Kras
Kirsten rat sarcoma viral oncogene homolog
increases mutagenesis
EXP
cyclopenta(c,d)pyrene results in increased mutagenesis of KRAS gene
CTD
PMID:9659573
NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965
G
Abcc5
ATP-binding cassette, sub-family C member 5
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of ABCC5 mRNA
CTD
PMID:32251684
NCBI chr16:20,150,053...20,245,178
Ensembl chr16:20,150,053...20,245,144
G
Acsm3
acyl-CoA synthetase medium-chain family member 3
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of ACSM3 mRNA
CTD
PMID:26377693
NCBI chr 7:119,360,106...119,384,119
Ensembl chr 7:119,360,146...119,386,736
G
Adamts15
ADAM metallopeptidase with thrombospondin type 1 motif 15
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of ADAMTS15 mRNA
CTD
PMID:26377693
NCBI chr 9:30,810,451...30,833,853
Ensembl chr 9:30,810,451...30,833,748
G
Adig
adipogenin
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of ADIG mRNA
CTD
PMID:26377693
NCBI chr 2:158,344,532...158,350,118
Ensembl chr 2:158,344,532...158,350,118
G
Adipoq
adiponectin, C1Q and collagen domain containing
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of ADIPOQ mRNA
CTD
PMID:26377693
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Adora1
adenosine A1 receptor
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of ADORA1 mRNA
CTD
PMID:32251684
NCBI chr 1:134,126,953...134,163,195
Ensembl chr 1:134,126,963...134,163,169
G
Ahr
aryl-hydrocarbon receptor
multiple interactions increases expression increases activity
ISO EXP
1-methyltryptophan inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of AHR protein]; 2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [indeno(1,2,3-cd)pyrene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene] promotes the reaction [pyrene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with pyrene] promotes the reaction [fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [chrysene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benzo(k)fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benzo(j)fluoranthene results in increased activity of AHR protein]; [benz(a)anthracene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [Benzo(a)pyrene results in increased activity of AHR protein]; [Benzo(a)pyrene co-treated with benzo(j)fluoranthene co-treated with benzo(k)fluoranthene co-treated with chrysene co-treated with indeno(1,2,3-cd)pyrene co-treated with fluoranthene co-treated with pyrene] promotes the reaction [benz(a)anthracene results in increased activity of AHR protein]; [indeno(1,2,3-cd)pyrene results in increased expression of AHR protein] which results in increased abundance of Kynurenine; AHR promotes the reaction [indeno(1,2,3-cd)pyrene results in increased expression of IKZF1 protein]; AHR promotes the reaction [indeno(1,2,3-cd)pyrene results in increased expression of POU5F1 protein]; AHR protein promotes the reaction [indeno(1,2,3-cd)pyrene results in increased expression of CCND1 protein]; AHR protein promotes the reaction [indeno(1,2,3-cd)pyrene results in increased expression of E2F1 protein]; AHR protein promotes the reaction [indeno(1,2,3-cd)pyrene results in increased expression of ETV6 protein]; AHR protein promotes the reaction [indeno(1,2,3-cd)pyrene results in increased expression of MKI67 protein]; AHR protein promotes the reaction [indeno(1,2,3-cd)pyrene results in increased expression of MYC protein]; AHR protein promotes the reaction [indeno(1,2,3-cd)pyrene results in increased expression of RUNX1 protein]; epacadostat inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of AHR protein]; indeno(1,2,3-cd)pyrene promotes the reaction [AHR protein results in increased expression of CYP1A1 mRNA]; U 0126 inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of AHR protein] AHR protein affects the reaction [[indeno(1,2,3-cd)pyrene co-treated with Antigens, Dermatophagoides] results in increased expression of IRF4 mRNA]; AHR protein affects the reaction [indeno(1,2,3-cd)pyrene promotes the reaction [Antigens, Dermatophagoides results in increased expression of BCL6 mRNA]]; AHR protein affects the reaction [indeno(1,2,3-cd)pyrene promotes the reaction [Antigens, Dermatophagoides results in increased expression of IL21 mRNA]] indeno(1,2,3-cd)pyrene results in increased expression of AHR mRNA; indeno(1,2,3-cd)pyrene results in increased expression of AHR protein indeno(1,2,3-cd)pyrene binds to and results in increased activity of AHR protein
CTD
PMID:11525907 PMID:12371477 PMID:12850102 PMID:17665671 PMID:21781905 PMID:25500124 PMID:35687267 PMID:36975775 More...
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
G
Ahrr
aryl-hydrocarbon receptor repressor
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of AHRR mRNA
CTD
PMID:32251684
NCBI chr13:74,359,237...74,440,450
Ensembl chr13:74,359,237...74,440,450
G
Akr1c20
aldo-keto reductase family 1, member C20
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of AKR1C1 mRNA
CTD
PMID:17253728
NCBI chr13:4,536,855...4,573,353
Ensembl chr13:4,536,848...4,573,344
G
Aldh1a2
aldehyde dehydrogenase family 1, subfamily A2
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of ALDH1A2 mRNA
CTD
PMID:26377693
NCBI chr 9:71,123,071...71,203,525
Ensembl chr 9:71,123,071...71,203,525
G
Aldh1a3
aldehyde dehydrogenase family 1, subfamily A3
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of ALDH1A3 mRNA
CTD
PMID:32251684
NCBI chr 7:66,040,640...66,077,225
Ensembl chr 7:66,040,638...66,077,265
G
Aldh3a1
aldehyde dehydrogenase family 3, subfamily A1
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of ALDH3A1 mRNA
CTD
PMID:32251684
NCBI chr11:61,099,336...61,109,244
Ensembl chr11:61,098,363...61,109,247
G
Amer2
APC membrane recruitment 2
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of AMER2 mRNA
CTD
PMID:32251684
NCBI chr14:60,615,141...60,625,642
Ensembl chr14:60,610,708...60,625,646
G
Amy1
amylase 1, salivary
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of AMY1 mRNA
CTD
PMID:26377693
NCBI chr 3:113,349,601...113,371,399
Ensembl chr 3:113,349,359...113,400,348
G
Angptl4
angiopoietin-like 4
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of ANGPTL4 mRNA
CTD
PMID:26377693
NCBI chr17:33,993,874...34,000,549
Ensembl chr17:33,992,724...34,000,804
G
Areg
amphiregulin
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of AREG mRNA
CTD
PMID:26377693
NCBI chr 5:91,287,458...91,296,291
Ensembl chr 5:91,287,458...91,296,291
G
Arl4d
ADP-ribosylation factor-like 4D
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of ARL4D mRNA
CTD
PMID:26377693
NCBI chr11:101,556,367...101,558,658
Ensembl chr11:101,556,367...101,558,658
G
Arxes2
adipocyte-related X-chromosome expressed sequence 2
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of ARXES2 mRNA
CTD
PMID:26377693
NCBI chr X:134,894,569...134,896,108
Ensembl chr X:134,894,573...134,896,104
G
Asgr2
asialoglycoprotein receptor 2
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of ASGR2 mRNA
CTD
PMID:26377693
NCBI chr11:69,983,470...69,997,013
Ensembl chr11:69,983,470...69,997,013
G
Atoh8
atonal bHLH transcription factor 8
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of ATOH8 mRNA
CTD
PMID:32251684
NCBI chr 6:72,183,158...72,212,765
Ensembl chr 6:72,183,161...72,212,561
G
Baiap2l1
BAI1-associated protein 2-like 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of BAIAP2L1 mRNA
CTD
PMID:26377693
NCBI chr 5:144,201,335...144,294,922
Ensembl chr 5:144,201,336...144,294,922
G
Batf
basic leucine zipper transcription factor, ATF-like
multiple interactions
EXP
[indeno(1,2,3-cd)pyrene co-treated with Antigens, Dermatophagoides] results in increased expression of BATF mRNA
CTD
PMID:36975775
NCBI chr12:85,733,494...85,755,861
Ensembl chr12:85,733,443...85,755,861
G
Bche
butyrylcholinesterase
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of BCHE mRNA
CTD
PMID:26377693
NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
G
Bcl6
B cell leukemia/lymphoma 6
decreases expression multiple interactions
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of BCL6 mRNA 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [indeno(1,2,3-cd)pyrene promotes the reaction [Antigens, Dermatophagoides results in increased expression of BCL6 mRNA]]; AHR protein affects the reaction [indeno(1,2,3-cd)pyrene promotes the reaction [Antigens, Dermatophagoides results in increased expression of BCL6 mRNA]]; indeno(1,2,3-cd)pyrene promotes the reaction [Antigens, Dermatophagoides results in increased expression of BCL6 mRNA]
CTD
PMID:26377693 PMID:36975775
NCBI chr16:23,780,058...23,807,602
Ensembl chr16:23,783,802...23,807,602
G
Bmal1
basic helix-loop-helix ARNT like 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of BMAL1 mRNA
CTD
PMID:26377693
NCBI chr 7:112,777,820...112,913,333
Ensembl chr 7:112,806,672...112,913,333
G
Bnc1
basonuclin zinc finger protein 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of BNC1 mRNA
CTD
PMID:26377693
NCBI chr 7:81,616,401...81,642,047
Ensembl chr 7:81,616,401...81,642,055
G
Bpifa1
BPI fold containing family A, member 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of BPIFA1 mRNA
CTD
PMID:26377693
NCBI chr 2:153,984,800...153,991,137
Ensembl chr 2:153,984,800...153,991,139
G
C2
complement C2
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of C2 mRNA
CTD
PMID:26377693
NCBI chr17:35,081,578...35,101,076
Ensembl chr17:35,081,580...35,117,241
G
Cacybp
calcyclin binding protein
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of CACYBP mRNA
CTD
PMID:26377693
NCBI chr 1:160,029,171...160,040,391
Ensembl chr 1:160,029,937...160,040,445
G
Cadm1
cell adhesion molecule 1
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of CADM1 mRNA
CTD
PMID:21635667
NCBI chr 9:47,441,468...47,773,578
Ensembl chr 9:47,441,471...47,769,413
G
Car14
carbonic anhydrase 14
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of CAR14 mRNA
CTD
PMID:26377693
NCBI chr 3:95,805,080...95,812,443
Ensembl chr 3:95,805,080...95,812,003
G
Car3
carbonic anhydrase 3
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of CAR3 mRNA
CTD
PMID:26377693
NCBI chr 3:14,928,598...14,937,441
Ensembl chr 3:14,928,572...14,937,583
G
Ccdc80
coiled-coil domain containing 80
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of CCDC80 mRNA
CTD
PMID:26377693
NCBI chr16:44,913,770...44,948,287
Ensembl chr16:44,913,765...44,948,440
G
Ccdc85a
coiled-coil domain containing 85A
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of CCDC85A mRNA
CTD
PMID:26377693
NCBI chr11:28,335,688...28,537,234
Ensembl chr11:28,335,685...28,534,324
G
Ccl8
C-C motif chemokine ligand 8
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of CCL8 mRNA
CTD
PMID:26377693
NCBI chr11:82,006,011...82,007,625
Ensembl chr11:82,006,011...82,007,625
G
Ccna2
cyclin A2
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of CCNA2 mRNA
CTD
PMID:32251684
NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
G
Ccnd1
cyclin D1
increases expression multiple interactions
ISO
indeno(1,2,3-cd)pyrene results in increased expression of CCND1 mRNA 1-methyltryptophan inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of CCND1 protein]; 2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of CCND1 protein]; AHR protein promotes the reaction [indeno(1,2,3-cd)pyrene results in increased expression of CCND1 protein]; epacadostat inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of CCND1 protein]; U 0126 inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of CCND1 protein]
CTD
PMID:35687267
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
G
Ccng2
cyclin G2
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of CCNG2 mRNA
CTD
PMID:32251684
NCBI chr 5:93,415,432...93,424,090
Ensembl chr 5:93,415,116...93,424,090
G
Ccnjl
cyclin J-like
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of CCNJL mRNA
CTD
PMID:26377693
NCBI chr11:43,419,576...43,477,826
Ensembl chr11:43,419,611...43,477,824
G
Cebpb
CCAAT/enhancer binding protein beta
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of CEBPB mRNA
CTD
PMID:32251684
NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
G
Cebpd
CCAAT/enhancer binding protein delta
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of CEBPD mRNA
CTD
PMID:26377693
NCBI chr16:15,705,150...15,707,409
Ensembl chr16:15,705,150...15,708,895
G
Celsr2
cadherin, EGF LAG seven-pass G-type receptor 2
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of CELSR2 mRNA
CTD
PMID:21635667 PMID:32251684
NCBI chr 3:108,298,164...108,323,416
Ensembl chr 3:108,298,167...108,323,383
G
Cenpa
centromere protein A
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of CENPA mRNA
CTD
PMID:32251684
NCBI chr 5:30,824,214...30,832,181
Ensembl chr 5:30,824,121...30,832,174
G
Cfd
complement factor D
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of CFD mRNA
CTD
PMID:26377693
NCBI chr10:79,726,687...79,728,489
Ensembl chr10:79,726,687...79,728,489
G
Chordc1
cysteine and histidine rich domain containing 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of CHORDC1 mRNA
CTD
PMID:26377693
NCBI chr 9:18,203,563...18,225,296
Ensembl chr 9:18,203,421...18,228,738
G
Cidea
cell death-inducing DNA fragmentation factor, alpha subunit-like effector A
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of CIDEA mRNA
CTD
PMID:26377693
NCBI chr18:67,476,634...67,500,864
Ensembl chr18:67,476,674...67,500,855
G
Ckmt2
creatine kinase, mitochondrial 2
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of CKMT2 mRNA
CTD
PMID:26377693
NCBI chr13:92,001,510...92,025,001
Ensembl chr13:92,001,506...92,025,004
G
Cldn17
claudin 17
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of CLDN17 mRNA
CTD
PMID:21635667
NCBI chr16:88,302,695...88,303,866
Ensembl chr16:88,302,695...88,303,866
G
Clec10a
C-type lectin domain family 10, member A
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of CLEC10A mRNA
CTD
PMID:26377693
NCBI chr11:70,057,449...70,061,662
Ensembl chr11:70,047,023...70,061,660
G
Clec9a
C-type lectin domain family 9, member a
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of CLEC9A mRNA
CTD
PMID:26377693
NCBI chr 6:129,385,825...129,401,727
Ensembl chr 6:129,385,825...129,401,726
G
Clic4
chloride intracellular channel 4
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of CLIC4 mRNA
CTD
PMID:26377693
NCBI chr 4:134,941,280...135,000,071
Ensembl chr 4:134,941,280...135,000,125
G
Col2a1
collagen, type II, alpha 1
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of COL2A1 mRNA
CTD
PMID:21635667
NCBI chr15:97,873,483...97,902,525
Ensembl chr15:97,873,483...97,902,576
G
Col4a6
collagen, type IV, alpha 6
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of COL4A6 mRNA
CTD
PMID:21635667
NCBI chr X:139,948,399...140,257,091
Ensembl chr X:139,948,399...140,257,072
G
Cox7a1
cytochrome c oxidase subunit 7A1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of COX7A1 mRNA
CTD
PMID:26377693
NCBI chr 7:29,883,596...29,885,455
Ensembl chr 7:29,883,569...29,885,503
G
Cox8b
cytochrome c oxidase subunit 8B
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of COX8B mRNA
CTD
PMID:26377693
NCBI chr 7:140,478,855...140,480,359
Ensembl chr 7:140,478,858...140,480,359
G
Creb1
cAMP responsive element binding protein 1
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of CREB1 mRNA
CTD
PMID:32251684
NCBI chr 1:64,571,963...64,643,707
Ensembl chr 1:64,571,804...64,643,707
G
Csrp3
cysteine and glycine-rich protein 3
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of CSRP3 mRNA
CTD
PMID:26377693
NCBI chr 7:48,480,146...48,497,799
Ensembl chr 7:48,480,146...48,497,781
G
Ctsb
cathepsin B
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of CTSB mRNA
CTD
PMID:32251684
NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372
G
Ctsd
cathepsin D
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of CTSD mRNA
CTD
PMID:32251684
NCBI chr 7:141,929,647...141,941,564
Ensembl chr 7:141,929,648...141,941,775
G
Cxcl12
C-X-C motif chemokine ligand 12
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of CXCL12 mRNA
CTD
PMID:32251684
NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328
G
Cxcl15
C-X-C motif chemokine ligand 15
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of CXCL5 mRNA
CTD
PMID:26377693
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions increases expression increases activity
ISO EXP
Dexamethasone inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of CYP1A1 protein]; indeno(1,2,3-cd)pyrene promotes the reaction [AHR protein results in increased expression of CYP1A1 mRNA] [indeno(1,2,3-cd)pyrene co-treated with Antigens, Dermatophagoides] results in increased expression of CYP1A1 mRNA indeno(1,2,3-cd)pyrene results in increased activity of CYP1A1 protein indeno(1,2,3-cd)pyrene results in increased expression of CYP1A1 mRNA; indeno(1,2,3-cd)pyrene results in increased expression of CYP1A1 protein
CTD
PMID:10190573 PMID:17253728 PMID:19463884 PMID:21781905 PMID:26377693 PMID:27196671 PMID:32251684 PMID:36975775 More...
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of CYP1A2 mRNA
CTD
PMID:17253728
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression multiple interactions
ISO
indeno(1,2,3-cd)pyrene results in increased expression of CYP1B1 mRNA; indeno(1,2,3-cd)pyrene results in increased expression of CYP1B1 protein 1-methyltryptophan inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of CYP1B1 protein]; 2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of CYP1B1 protein]; epacadostat inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of CYP1B1 protein]; U 0126 inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of CYP1B1 protein]
CTD
PMID:17253728 PMID:27196671 PMID:35687267
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
G
Ddit4
DNA-damage-inducible transcript 4
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of DDIT4 mRNA
CTD
PMID:32251684
NCBI chr10:59,785,497...59,787,592
Ensembl chr10:59,785,491...59,787,656
G
Dgat2
diacylglycerol O-acyltransferase 2
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of DGAT2 mRNA
CTD
PMID:26377693
NCBI chr 7:98,802,870...98,831,920
Ensembl chr 7:98,802,865...98,831,926
G
Dnaaf10
dynein axonemal assembly factor 10
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of DNAAF10 mRNA
CTD
PMID:26377693
NCBI chr11:17,161,893...17,185,200
Ensembl chr11:17,132,107...17,183,796
G
Dnaja1
DnaJ heat shock protein family (Hsp40) member A1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of DNAJA1 mRNA
CTD
PMID:26377693
NCBI chr 4:40,722,468...40,734,965
Ensembl chr 4:40,722,150...40,737,149
G
Dpt
dermatopontin
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of DPT mRNA
CTD
PMID:26377693
NCBI chr 1:164,624,232...164,651,843
Ensembl chr 1:164,624,213...164,651,835
G
Dvl3
dishevelled segment polarity protein 3
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of DVL3 mRNA
CTD
PMID:26377693
NCBI chr16:20,335,694...20,352,763
Ensembl chr16:20,335,732...20,352,760
G
Dynll1
dynein light chain LC8-type 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of DYNLL1 mRNA
CTD
PMID:26377693
NCBI chr 5:115,435,129...115,438,995
Ensembl chr 5:115,435,169...115,439,058
G
E2f1
E2F transcription factor 1
multiple interactions increases expression
ISO
1-methyltryptophan inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of E2F1 protein]; 2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of E2F1 protein]; AHR protein promotes the reaction [indeno(1,2,3-cd)pyrene results in increased expression of E2F1 protein]; epacadostat inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of E2F1 protein]; U 0126 inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of E2F1 protein] indeno(1,2,3-cd)pyrene results in increased expression of E2F1 mRNA; indeno(1,2,3-cd)pyrene results in increased expression of E2F1 protein
CTD
PMID:35687267
NCBI chr 2:154,401,320...154,411,812
Ensembl chr 2:154,401,327...154,411,812
G
Efemp1
epidermal growth factor-containing fibulin-like extracellular matrix protein 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of EFEMP1 mRNA
CTD
PMID:26377693
NCBI chr11:28,803,154...28,876,743
Ensembl chr11:28,803,204...28,876,743
G
Elovl6
ELOVL fatty acid elongase 6
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of ELOVL6 mRNA
CTD
PMID:26377693
NCBI chr 3:129,326,035...129,432,144
Ensembl chr 3:129,326,004...129,432,144
G
Ephb6
Eph receptor B6
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of EPHB6 mRNA
CTD
PMID:26377693
NCBI chr 6:41,581,940...41,597,445
Ensembl chr 6:41,582,416...41,597,443
G
Erbb2
erb-b2 receptor tyrosine kinase 2
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of ERBB2 mRNA
CTD
PMID:21635667
NCBI chr11:98,303,310...98,328,542
Ensembl chr11:98,303,296...98,328,542
G
Errfi1
ERBB receptor feedback inhibitor 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of ERRFI1 mRNA
CTD
PMID:26377693
NCBI chr 4:150,938,253...150,953,346
Ensembl chr 4:150,938,376...150,953,349
G
Esr1
estrogen receptor 1 (alpha)
affects binding
ISO
indeno(1,2,3-cd)pyrene binds to ESR1 protein
CTD
PMID:32251684
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Ets1
E26 avian leukemia oncogene 1, 5' domain
multiple interactions increases expression
ISO
Acetylcysteine inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of ETS1 mRNA]; SB 203580 inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of ETS1 mRNA]
CTD
PMID:21635667
NCBI chr 9:32,547,501...32,669,116
Ensembl chr 9:32,547,517...32,669,116
G
Etv6
ets variant 6
multiple interactions increases expression
ISO
1-methyltryptophan inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of ETV6 protein]; AHR protein promotes the reaction [indeno(1,2,3-cd)pyrene results in increased expression of ETV6 protein]; epacadostat inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of ETV6 protein] indeno(1,2,3-cd)pyrene results in increased expression of ETV6 mRNA; indeno(1,2,3-cd)pyrene results in increased expression of ETV6 protein
CTD
PMID:35687267
NCBI chr 6:134,012,663...134,247,121
Ensembl chr 6:134,012,663...134,247,121
G
Fabp4
fatty acid binding protein 4, adipocyte
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of FABP4 mRNA
CTD
PMID:26377693
NCBI chr 3:10,269,406...10,273,653
Ensembl chr 3:10,269,148...10,273,636
G
Fam181b
family with sequence similarity 181, member B
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of FAM181B mRNA
CTD
PMID:26377693
NCBI chr 7:92,729,087...92,730,929
Ensembl chr 7:92,729,073...92,731,074
G
Fibin
fin bud initiation factor homolog (zebrafish)
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of FIBIN mRNA
CTD
PMID:26377693
NCBI chr 2:110,191,270...110,193,338
Ensembl chr 2:110,191,262...110,193,528
G
Fos
FBJ osteosarcoma oncogene
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of FOS mRNA
CTD
PMID:32251684
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Frem1
Fras1 related extracellular matrix protein 1
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of FREM1 mRNA
CTD
PMID:21635667
NCBI chr 4:82,816,157...82,970,743
Ensembl chr 4:82,816,164...82,970,576
G
Fsbp
fibrinogen silencer binding protein
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of FSBP mRNA
CTD
PMID:32251684
NCBI chr 4:11,579,662...11,587,802
Ensembl chr 4:11,579,665...11,587,591
G
Gdpd2
glycerophosphodiester phosphodiesterase domain containing 2
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of GDPD2 mRNA
CTD
PMID:26377693
NCBI chr X:99,773,442...99,782,507
Ensembl chr X:99,773,479...99,782,501
G
Gfpt2
glutamine fructose-6-phosphate transaminase 2
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of GFPT2 mRNA
CTD
PMID:26377693
NCBI chr11:49,684,981...49,729,448
Ensembl chr11:49,685,005...49,729,440
G
Gjb2
gap junction protein, beta 2
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of GJB2 mRNA
CTD
PMID:32251684
NCBI chr14:57,336,059...57,342,159
Ensembl chr14:57,336,057...57,342,159
G
Golph3l
golgi phosphoprotein 3-like
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of GOLPH3L mRNA
CTD
PMID:26377693
NCBI chr 3:95,496,280...95,526,553
Ensembl chr 3:95,496,245...95,526,553
G
Gpd1
glycerol-3-phosphate dehydrogenase 1 (soluble)
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of GPD1 mRNA
CTD
PMID:26377693
NCBI chr15:99,615,468...99,622,895
Ensembl chr15:99,615,396...99,622,886
G
Gpm6a
glycoprotein m6a
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of GPM6A mRNA
CTD
PMID:26377693
NCBI chr 8:55,232,469...55,513,913
Ensembl chr 8:55,407,878...55,513,906
G
Grifin
galectin-related inter-fiber protein
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of GRIFIN mRNA
CTD
PMID:26377693
NCBI chr 5:140,548,872...140,553,280
Ensembl chr 5:140,548,874...140,550,826
G
Grp
gastrin releasing peptide
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of GRP mRNA
CTD
PMID:26377693
NCBI chr18:66,005,826...66,019,670
Ensembl chr18:66,005,891...66,019,667
G
Gxylt2
glucoside xylosyltransferase 2
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of GXYLT2 mRNA
CTD
PMID:26377693
NCBI chr 6:100,681,638...100,787,738
Ensembl chr 6:100,681,695...100,787,874
G
Gzma
granzyme A
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of GZMA mRNA
CTD
PMID:26377693
NCBI chr13:113,230,358...113,237,515
Ensembl chr13:113,230,359...113,237,515
G
Has1
hyaluronan synthase 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of HAS1 mRNA
CTD
PMID:26377693
NCBI chr17:18,063,588...18,075,450
Ensembl chr17:18,063,585...18,075,467
G
Hmox1
heme oxygenase 1
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of HMOX1 mRNA
CTD
PMID:32251684
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hrc
histidine rich calcium binding protein
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of HRC mRNA
CTD
PMID:26377693
NCBI chr 7:44,984,693...44,988,397
Ensembl chr 7:44,984,714...44,988,398
G
Hsp90aa1
heat shock protein 90, alpha (cytosolic), class A member 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of HSP90AA1 mRNA
CTD
PMID:26377693
NCBI chr12:110,657,470...110,662,829
Ensembl chr12:110,657,039...110,669,162
G
Hspa1a
heat shock protein 1A
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of HSPA1A mRNA
CTD
PMID:26377693
NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132
G
Hspa8
heat shock protein 8
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of HSPA8 mRNA
CTD
PMID:26377693
NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
G
Hspd1
heat shock protein 1 (chaperonin)
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of HSPD1 mRNA
CTD
PMID:26377693
NCBI chr 1:55,116,992...55,127,402
Ensembl chr 1:55,116,994...55,127,402
G
Hsph1
heat shock 105kDa/110kDa protein 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of HSPH1 mRNA
CTD
PMID:26377693
NCBI chr 5:149,540,308...149,562,594
Ensembl chr 5:149,537,752...149,559,841
G
Ido1
indoleamine 2,3-dioxygenase 1
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of IDO1 protein
CTD
PMID:35687267
NCBI chr 8:25,074,148...25,086,987
Ensembl chr 8:25,074,152...25,087,025
G
Ido2
indoleamine 2,3-dioxygenase 2
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of IDO2 protein
CTD
PMID:35687267
NCBI chr 8:25,021,908...25,066,430
Ensembl chr 8:25,021,908...25,066,349
G
Ier3
immediate early response 3
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of IER3 mRNA
CTD
PMID:22579512 PMID:32251684
NCBI chr17:36,132,605...36,133,803
Ensembl chr17:36,132,576...36,133,815
G
Ifi211
interferon activated gene 211
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of MNDA mRNA
CTD
PMID:26377693
NCBI chr 1:173,723,907...173,740,650
Ensembl chr 1:173,723,911...173,740,612
G
Igf1r
insulin-like growth factor I receptor
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of IGF1R mRNA
CTD
PMID:32251684
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
G
Igfbp5
insulin-like growth factor binding protein 5
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of IGFBP5 mRNA
CTD
PMID:26377693
NCBI chr 1:72,897,224...72,914,024
Ensembl chr 1:72,897,091...72,914,043
G
Igh-VJ558
immunoglobulin heavy chain (J558 family)
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of IGH-VJ558 mRNA
CTD
PMID:26377693
G
Ighg2a
immunoglobulin heavy constant gamma 2A
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of IGHG2A mRNA
CTD
PMID:26377693
G
Ikzf1
IKAROS family zinc finger 1
multiple interactions increases expression
ISO
AHR promotes the reaction [indeno(1,2,3-cd)pyrene results in increased expression of IKZF1 protein] indeno(1,2,3-cd)pyrene results in increased expression of IKZF1 mRNA; indeno(1,2,3-cd)pyrene results in increased expression of IKZF1 protein
CTD
PMID:35687267
NCBI chr11:11,634,970...11,722,930
Ensembl chr11:11,634,980...11,722,926
G
Il21
interleukin 21
multiple interactions
EXP
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [indeno(1,2,3-cd)pyrene promotes the reaction [Antigens, Dermatophagoides results in increased expression of IL21 mRNA]]; AHR protein affects the reaction [indeno(1,2,3-cd)pyrene promotes the reaction [Antigens, Dermatophagoides results in increased expression of IL21 mRNA]]; indeno(1,2,3-cd)pyrene promotes the reaction [Antigens, Dermatophagoides results in increased expression of IL21 mRNA]; MAF protein affects the reaction [indeno(1,2,3-cd)pyrene promotes the reaction [Antigens, Dermatophagoides results in increased expression of IL21 mRNA]]
CTD
PMID:36975775
NCBI chr 3:37,276,908...37,286,785
Ensembl chr 3:37,276,908...37,286,785
G
Il4
interleukin 4
multiple interactions
EXP
[indeno(1,2,3-cd)pyrene co-treated with Antigens, Dermatophagoides] results in increased expression of IL4 mRNA; MAF protein affects the reaction [[indeno(1,2,3-cd)pyrene co-treated with Antigens, Dermatophagoides] results in increased expression of IL4 mRNA]
CTD
PMID:36975775
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
G
Iqsec1
IQ motif and Sec7 domain 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of IQSEC1 mRNA
CTD
PMID:26377693
NCBI chr 6:90,636,578...90,965,766
Ensembl chr 6:90,633,070...90,965,667
G
Irf2bp2
interferon regulatory factor 2 binding protein 2
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of IRF2BP2 mRNA
CTD
PMID:26377693
NCBI chr 8:127,315,035...127,320,725
Ensembl chr 8:127,315,035...127,320,725
G
Irf4
interferon regulatory factor 4
multiple interactions
EXP
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[indeno(1,2,3-cd)pyrene co-treated with Antigens, Dermatophagoides] results in increased expression of IRF4 mRNA]; [indeno(1,2,3-cd)pyrene co-treated with Antigens, Dermatophagoides] results in increased expression of IRF4 mRNA; AHR protein affects the reaction [[indeno(1,2,3-cd)pyrene co-treated with Antigens, Dermatophagoides] results in increased expression of IRF4 mRNA]
CTD
PMID:36975775
NCBI chr13:30,933,191...30,950,965
Ensembl chr13:30,933,209...30,950,959
G
Isx
intestine specific homeobox
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of ISX protein
CTD
PMID:35687267
NCBI chr 8:75,599,326...75,620,134
Ensembl chr 8:75,599,801...75,620,134
G
Itga2
integrin alpha 2
multiple interactions increases expression
ISO
Acetylcysteine inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of ITGA2 mRNA]; SB 203580 inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of ITGA2 mRNA]
CTD
PMID:21635667
NCBI chr13:114,969,617...115,068,588
Ensembl chr13:114,969,617...115,068,636
G
Itga6
integrin alpha 6
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of ITGA6 mRNA
CTD
PMID:26377693
NCBI chr 2:71,617,236...71,688,761
Ensembl chr 2:71,575,960...71,688,760
G
Itgb6
integrin beta 6
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of ITGB6 mRNA
CTD
PMID:26377693
NCBI chr 2:60,428,636...60,553,005
Ensembl chr 2:60,428,636...60,552,987
G
Jchain
immunoglobulin joining chain
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of JCHAIN mRNA
CTD
PMID:26377693
NCBI chr 5:88,667,663...88,675,667
Ensembl chr 5:88,667,668...88,675,750
G
Jun
jun proto-oncogene
multiple interactions increases expression
ISO
Acetylcysteine inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of JUN mRNA]; SB 203580 inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of JUN mRNA]
CTD
PMID:21635667
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
G
Kdm1b
lysine (K)-specific demethylase 1B
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of KDM1B mRNA
CTD
PMID:26377693
NCBI chr13:47,196,849...47,238,085
Ensembl chr13:47,196,975...47,238,755
G
Kitl
kit ligand
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of KITL mRNA
CTD
PMID:26377693
NCBI chr10:99,851,477...99,936,278
Ensembl chr10:99,851,492...99,936,278
G
Klhl23
kelch-like 23
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of PHOSPHO2-KLHL23 mRNA
CTD
PMID:32251684
NCBI chr 2:69,652,285...69,666,995
Ensembl chr 2:69,652,288...69,666,995
G
Klk1
kallikrein 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of KLK1 mRNA
CTD
PMID:26377693
NCBI chr 7:43,874,784...43,879,046
Ensembl chr 7:43,874,784...43,879,042
G
Klra15
killer cell lectin-like receptor, subfamily A, member 15
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of KLRA15 mRNA
CTD
PMID:26377693
G
Klra16
killer cell lectin-like receptor, subfamily A, member 16
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of KLRA16 mRNA
CTD
PMID:26377693
G
Klra22
killer cell lectin-like receptor subfamily A, member 22
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of KLRA22 mRNA
CTD
PMID:26377693
G
Klra4
killer cell lectin-like receptor, subfamily A, member 4
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of KLRA4 mRNA
CTD
PMID:26377693
NCBI chr 6:130,020,693...130,044,242
Ensembl chr 6:130,020,694...130,044,234
G
Knstrn
kinetochore-localized astrin/SPAG5 binding
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of KNSTRN mRNA
CTD
PMID:26377693
NCBI chr 2:118,644,470...118,667,691
Ensembl chr 2:118,644,484...118,684,438
G
Krt19
keratin 19
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of KRT19 mRNA
CTD
PMID:32251684
NCBI chr11:100,031,636...100,036,752
Ensembl chr11:100,031,636...100,039,491
G
Lgals1
lectin, galactose binding, soluble 1
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of LGALS1 mRNA
CTD
PMID:22579512
NCBI chr15:78,810,925...78,814,665
Ensembl chr15:78,810,925...78,814,665
G
Lonrf3
LON peptidase N-terminal domain and ring finger 3
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of LONRF3 mRNA
CTD
PMID:26377693
NCBI chr X:35,592,011...35,630,510
Ensembl chr X:35,592,006...35,625,994
G
Lpin2
lipin 2
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of LPIN2 mRNA
CTD
PMID:26377693
NCBI chr17:71,490,527...71,556,813
Ensembl chr17:71,489,555...71,556,812
G
Lrrn4
leucine rich repeat neuronal 4
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of LRRN4 mRNA
CTD
PMID:26377693
NCBI chr 2:132,710,436...132,735,930
Ensembl chr 2:132,710,225...132,722,811
G
Maf
MAF bZIP transcription factor
multiple interactions
EXP
indeno(1,2,3-cd)pyrene promotes the reaction [Antigens, Dermatophagoides results in increased expression of MAF mRNA]; MAF protein affects the reaction [[indeno(1,2,3-cd)pyrene co-treated with Antigens, Dermatophagoides] results in increased expression of IL4 mRNA]; MAF protein affects the reaction [indeno(1,2,3-cd)pyrene promotes the reaction [Antigens, Dermatophagoides results in increased expression of IL21 mRNA]]
CTD
PMID:36975775
NCBI chr 8:116,429,992...116,433,633
Ensembl chr 8:116,409,681...116,434,533
G
Mapk14
mitogen-activated protein kinase 14
increases phosphorylation multiple interactions
ISO
indeno(1,2,3-cd)pyrene results in increased phosphorylation of MAPK14 protein Acetylcysteine inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased phosphorylation of MAPK14 protein]; SB 203580 inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased phosphorylation of MAPK14 protein]
CTD
PMID:21635667
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
G
Mb
myoglobin
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of MB mRNA
CTD
PMID:26377693
NCBI chr15:76,899,687...76,934,868
Ensembl chr15:76,899,687...76,934,870
G
Mdm2
transformed mouse 3T3 cell double minute 2
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of MDM2 mRNA
CTD
PMID:32251684
NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
G
Mef2b
myocyte enhancer factor 2B
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of MEF2B mRNA
CTD
PMID:32251684
NCBI chr 8:70,605,411...70,620,138
Ensembl chr 8:70,592,361...70,620,138
G
Mfap2
microfibrillar-associated protein 2
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of MFAP2 mRNA
CTD
PMID:26377693
NCBI chr 4:140,737,735...140,743,284
Ensembl chr 4:140,737,729...140,743,295
G
Mgat1
mannoside acetylglucosaminyltransferase 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of MGAT1 mRNA
CTD
PMID:26377693
NCBI chr11:49,135,018...49,153,854
Ensembl chr11:49,135,018...49,153,857
G
Mki67
antigen identified by monoclonal antibody Ki 67
increases expression multiple interactions
ISO
indeno(1,2,3-cd)pyrene results in increased expression of MKI67 mRNA; indeno(1,2,3-cd)pyrene results in increased expression of MKI67 protein 1-methyltryptophan inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of MKI67 protein]; AHR protein promotes the reaction [indeno(1,2,3-cd)pyrene results in increased expression of MKI67 protein]; epacadostat inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of MKI67 protein]
CTD
PMID:35687267
NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
G
Mmp2
matrix metallopeptidase 2
multiple interactions increases expression
ISO
Acetylcysteine inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of MMP2 mRNA]; SB 203580 inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of MMP2 mRNA]
CTD
PMID:21635667
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mmp3
matrix metallopeptidase 3
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of MMP3 mRNA
CTD
PMID:26377693
NCBI chr 9:7,445,845...7,455,975
Ensembl chr 9:7,445,822...7,455,975
G
Mrap
melanocortin 2 receptor accessory protein
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of MRAP mRNA
CTD
PMID:26377693
NCBI chr16:90,535,095...90,546,673
Ensembl chr16:90,535,095...90,546,673
G
Msln
mesothelin
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of MSLN mRNA
CTD
PMID:26377693
NCBI chr17:25,967,587...25,973,352
Ensembl chr17:25,967,587...25,973,352
G
Mtarc1
mitochondrial amidoxime reducing component 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of MTARC1 mRNA
CTD
PMID:26377693
NCBI chr 1:184,518,964...184,543,622
Ensembl chr 1:184,518,964...184,543,394
G
Muc16
mucin 16
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of MUC16 mRNA
CTD
PMID:26377693
NCBI chr 9:18,406,741...18,586,117
Ensembl chr 9:18,406,751...18,585,826
G
Mybpc3
myosin binding protein C, cardiac
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of MYBPC3 mRNA
CTD
PMID:26377693
NCBI chr 2:90,948,459...90,966,862
Ensembl chr 2:90,948,489...90,966,861
G
Myc
myelocytomatosis oncogene
multiple interactions
ISO
AHR protein promotes the reaction [indeno(1,2,3-cd)pyrene results in increased expression of MYC protein]
CTD
PMID:35687267
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
G
Myh6
myosin, heavy polypeptide 6, cardiac muscle, alpha
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of MYH6 mRNA
CTD
PMID:26377693
NCBI chr14:55,179,378...55,205,553
Ensembl chr14:55,179,378...55,204,384
G
Myl1
myosin, light polypeptide 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of MYL1 mRNA
CTD
PMID:26377693
NCBI chr 1:66,963,454...66,987,091
Ensembl chr 1:66,963,454...66,984,563
G
Myl4
myosin, light polypeptide 4
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of MYL4 mRNA
CTD
PMID:26377693
NCBI chr11:104,427,604...104,478,041
Ensembl chr11:104,441,489...104,486,579
G
Myl7
myosin, light polypeptide 7, regulatory
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of MYL7 mRNA
CTD
PMID:26377693
NCBI chr11:5,846,637...5,848,782
Ensembl chr11:5,846,637...5,848,782
G
Mylk
myosin, light polypeptide kinase
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of MYLK mRNA
CTD
PMID:21635667
NCBI chr16:34,565,569...34,822,806
Ensembl chr16:34,565,580...34,822,790
G
Nanog
Nanog homeobox
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of NANOG mRNA
CTD
PMID:35687267
NCBI chr 6:122,684,448...122,691,592
Ensembl chr 6:122,684,448...122,691,592
G
Ndc80
NDC80 kinetochore complex component
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of NDC80 mRNA
CTD
PMID:22579512
NCBI chr17:71,803,095...71,833,852
Ensembl chr17:71,803,095...71,833,852
G
Nedd4
neural precursor cell expressed, developmentally down-regulated 4
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of NEDD4 mRNA
CTD
PMID:26377693
NCBI chr 9:72,569,613...72,657,133
Ensembl chr 9:72,569,628...72,657,134
G
Nfil3
nuclear factor, interleukin 3, regulated
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of NFIL3 mRNA
CTD
PMID:26377693
NCBI chr13:53,121,245...53,136,914
Ensembl chr13:53,121,245...53,135,109
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of NQO1 mRNA
CTD
PMID:17253728
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Oasl1
2'-5' oligoadenylate synthetase-like 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of OASL1 mRNA
CTD
PMID:26377693
NCBI chr 5:115,061,236...115,075,970
Ensembl chr 5:115,061,299...115,075,974
G
Otop1
otopetrin 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of OTOP1 mRNA
CTD
PMID:26377693
NCBI chr 5:38,434,748...38,461,560
Ensembl chr 5:38,433,316...38,461,552
G
Pah
phenylalanine hydroxylase
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of PAH mRNA
CTD
PMID:22579512
NCBI chr10:87,357,657...87,419,999
Ensembl chr10:87,357,657...87,419,998
G
Pals2
protein associated with LIN7 2, MAGUK family member
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of PALS2 mRNA
CTD
PMID:26377693
NCBI chr 6:50,087,206...50,176,134
Ensembl chr 6:50,087,221...50,175,919
G
Parp1
poly (ADP-ribose) polymerase family, member 1
increases cleavage
ISO
indeno(1,2,3-cd)pyrene results in increased cleavage of PARP1 protein
CTD
PMID:21132278
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Pbx1
pre B cell leukemia homeobox 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of PBX1 mRNA
CTD
PMID:26377693
NCBI chr 1:167,946,933...168,259,898
Ensembl chr 1:167,946,933...168,259,839
G
Pck1
phosphoenolpyruvate carboxykinase 1, cytosolic
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of PCK1 mRNA
CTD
PMID:26377693
NCBI chr 2:172,994,866...173,001,067
Ensembl chr 2:172,994,841...173,001,066
G
Pde5a
phosphodiesterase 5A, cGMP-specific
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of PDE5A mRNA
CTD
PMID:26377693
NCBI chr 3:122,522,822...122,653,023
Ensembl chr 3:122,522,596...122,653,023
G
Pdk4
pyruvate dehydrogenase kinase, isoenzyme 4
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of PDK4 mRNA
CTD
PMID:26377693
NCBI chr 6:5,483,351...5,496,278
Ensembl chr 6:5,483,351...5,496,309
G
Pdzd2
PDZ domain containing 2
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of PDZD2 mRNA
CTD
PMID:26377693
NCBI chr15:12,359,797...12,740,052
Ensembl chr15:12,359,797...12,740,010
G
Pebp1
phosphatidylethanolamine binding protein 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of PEBP1 mRNA
CTD
PMID:26377693
NCBI chr 5:117,420,716...117,425,629
Ensembl chr 5:117,420,719...117,425,690
G
Penk
preproenkephalin
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of PENK mRNA
CTD
PMID:26377693
NCBI chr 4:4,133,536...4,138,815
Ensembl chr 4:4,133,531...4,138,819
G
Pgam2
phosphoglycerate mutase 2
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of PGAM2 mRNA
CTD
PMID:26377693
NCBI chr11:5,751,637...5,753,796
Ensembl chr11:5,751,640...5,753,733
G
Pgap2
post-GPI attachment to proteins 2
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of PGAP2 mRNA
CTD
PMID:26377693
NCBI chr 7:101,859,153...101,887,771
Ensembl chr 7:101,859,415...101,887,774
G
Pgr
progesterone receptor
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of PGR mRNA
CTD
PMID:32251684
NCBI chr 9:8,890,017...8,968,612
Ensembl chr 9:8,899,834...8,968,612
G
Phf19
PHD finger protein 19
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of PHF19 mRNA
CTD
PMID:32251684
NCBI chr 2:34,783,764...34,804,365
Ensembl chr 2:34,783,769...34,804,038
G
Pkib
protein kinase inhibitor beta, cAMP dependent, testis specific
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of PKIB mRNA
CTD
PMID:32251684
NCBI chr10:57,508,077...57,617,208
Ensembl chr10:57,508,077...57,617,208
G
Plin1
perilipin 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of PLIN1 mRNA
CTD
PMID:26377693
NCBI chr 7:79,370,912...79,382,652
Ensembl chr 7:79,369,966...79,382,651
G
Plin4
perilipin 4
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of PLIN4 mRNA
CTD
PMID:26377693
NCBI chr17:56,407,587...56,416,947
Ensembl chr17:56,407,591...56,416,803
G
Polr1b
polymerase (RNA) I polypeptide B
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of POLR1B mRNA
CTD
PMID:26377693
NCBI chr 2:128,942,891...128,969,980
Ensembl chr 2:128,942,915...128,968,514
G
Popdc2
popeye domain containing 2
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of POPDC2 mRNA
CTD
PMID:26377693
NCBI chr16:38,182,523...38,198,578
Ensembl chr16:38,182,571...38,198,578
G
Pou5f1
POU domain, class 5, transcription factor 1
increases expression multiple interactions
ISO
indeno(1,2,3-cd)pyrene results in increased expression of POU5F1 mRNA; indeno(1,2,3-cd)pyrene results in increased expression of POU5F1 protein 1-methyltryptophan inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of POU5F1 protein]; 2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of POU5F1 protein]; AHR promotes the reaction [indeno(1,2,3-cd)pyrene results in increased expression of POU5F1 protein]; epacadostat inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of POU5F1 protein]; U 0126 inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of POU5F1 protein]
CTD
PMID:35687267
NCBI chr17:35,816,929...35,821,674
Ensembl chr17:35,816,915...35,821,669
G
Ppp4r3b
protein phosphatase 4 regulatory subunit 3B
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of PPP4R3B mRNA
CTD
PMID:26377693
NCBI chr11:29,118,053...29,170,797
Ensembl chr11:29,122,890...29,170,797
G
Rara
retinoic acid receptor, alpha
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of RARA mRNA
CTD
PMID:32251684
NCBI chr11:98,818,626...98,865,768
Ensembl chr11:98,818,644...98,865,768
G
Reln
reelin
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of RELN mRNA
CTD
PMID:21635667
NCBI chr 5:22,089,452...22,549,703
Ensembl chr 5:22,089,452...22,549,700
G
Ret
ret proto-oncogene
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of RET mRNA
CTD
PMID:32251684
NCBI chr 6:118,128,709...118,174,705
Ensembl chr 6:118,128,706...118,174,679
G
Retn
resistin
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of RETN mRNA
CTD
PMID:26377693
NCBI chr 8:3,705,770...3,709,818
Ensembl chr 8:3,705,770...3,710,110
G
Rhoc
ras homolog family member C
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of RHOC mRNA
CTD
PMID:22579512
NCBI chr 3:104,696,350...104,701,775
Ensembl chr 3:104,695,691...104,701,775
G
Rora
RAR-related orphan receptor alpha
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of RORA mRNA
CTD
PMID:26377693
NCBI chr 9:68,560,627...69,295,528
Ensembl chr 9:68,561,068...69,295,528
G
Rprml
reprimo-like
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of RPRML mRNA
CTD
PMID:26377693
NCBI chr11:103,540,335...103,541,406
Ensembl chr11:103,540,396...103,541,405
G
Rsrp1
arginine/serine rich protein 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of RSRP1 mRNA
CTD
PMID:26377693
NCBI chr 4:134,650,936...134,654,681
Ensembl chr 4:134,650,903...134,654,982
G
Runx1
runt related transcription factor 1
increases expression multiple interactions
ISO
indeno(1,2,3-cd)pyrene results in increased expression of RUNX1 mRNA; indeno(1,2,3-cd)pyrene results in increased expression of RUNX1 protein 1-methyltryptophan inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of RUNX1 protein]; AHR protein promotes the reaction [indeno(1,2,3-cd)pyrene results in increased expression of RUNX1 protein]; epacadostat inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of RUNX1 protein]
CTD
PMID:35687267
NCBI chr16:92,398,354...92,622,962
Ensembl chr16:92,398,354...92,623,037
G
Runx2
runt related transcription factor 2
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of RUNX2 mRNA
CTD
PMID:32251684
NCBI chr17:44,806,873...45,125,518
Ensembl chr17:44,806,874...45,125,684
G
Sbsn
suprabasin
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of SBSN mRNA
CTD
PMID:26377693
NCBI chr 7:30,432,099...30,455,559
Ensembl chr 7:30,450,896...30,455,559
G
Scgb2b20
secretoglobin, family 2B, member 20
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of SCGB2B20 mRNA
CTD
PMID:26377693
NCBI chr 7:33,063,768...33,065,744
Ensembl chr 7:33,063,768...33,065,747
G
Sdcbp2
syndecan binding protein (syntenin) 2
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of SDCBP2 mRNA
CTD
PMID:26377693
NCBI chr 2:151,414,203...151,431,925
Ensembl chr 2:151,414,542...151,431,925
G
Sema3b
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of SEMA3B mRNA
CTD
PMID:32251684
NCBI chr 9:107,474,868...107,486,440
Ensembl chr 9:107,474,873...107,486,428
G
Septin3
septin 3
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of SEPTIN3 mRNA
CTD
PMID:26377693
NCBI chr15:82,153,003...82,178,775
Ensembl chr15:82,153,003...82,178,775
G
Serpina3m
serine (or cysteine) peptidase inhibitor, clade A, member 3M
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of SERPINA3M mRNA
CTD
PMID:26377693
NCBI chr12:104,353,424...104,360,518
Ensembl chr12:104,304,745...104,360,516
G
Sgk1
serum/glucocorticoid regulated kinase 1
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of SGK1 mRNA
CTD
PMID:32251684
NCBI chr10:21,758,083...21,875,802
Ensembl chr10:21,758,083...21,875,802
G
Shc3
src homology 2 domain-containing transforming protein C3
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of SHC3 mRNA
CTD
PMID:21635667
NCBI chr13:51,577,422...51,724,909
Ensembl chr13:51,585,077...51,723,523
G
Siah2
siah E3 ubiquitin protein ligase 2
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of SIAH2 mRNA
CTD
PMID:32251684
NCBI chr 3:58,582,370...58,599,857
Ensembl chr 3:58,582,359...58,599,821
G
Siglech
sialic acid binding Ig-like lectin H
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of SIGLECH mRNA
CTD
PMID:26377693
NCBI chr 7:55,417,916...55,429,196
Ensembl chr 7:55,417,926...55,428,673
G
Slc10a6
solute carrier family 10 (sodium/bile acid cotransporter family), member 6
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of SLC10A6 mRNA
CTD
PMID:26377693
NCBI chr 5:103,753,583...103,777,152
Ensembl chr 5:103,753,577...103,777,269
G
Slc1a5
solute carrier family 1 (neutral amino acid transporter), member 5
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of SLC1A5 mRNA
CTD
PMID:26377693
NCBI chr 7:16,515,259...16,532,199
Ensembl chr 7:16,515,265...16,532,199
G
Slc2a4
solute carrier family 2 (facilitated glucose transporter), member 4
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of SLC2A4 mRNA
CTD
PMID:26377693
NCBI chr11:69,833,112...69,839,040
Ensembl chr11:69,833,365...69,839,014
G
Slc2a5
solute carrier family 2 (facilitated glucose transporter), member 5
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of SLC2A5 mRNA
CTD
PMID:26377693
NCBI chr 4:150,203,801...150,228,625
Ensembl chr 4:150,203,740...150,228,626
G
Slc5a12
solute carrier family 5 (sodium/glucose cotransporter), member 12
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of SLC5A12 mRNA
CTD
PMID:26377693
NCBI chr 2:110,427,644...110,479,690
Ensembl chr 2:110,427,643...110,478,124
G
Slc5a3
solute carrier family 5 (inositol transporters), member 3
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of SLC5A3 mRNA
CTD
PMID:26377693
NCBI chr16:91,855,210...91,884,361
Ensembl chr16:91,855,210...91,884,361
G
Slc7a11
solute carrier family 7 (cationic amino acid transporter, y+ system), member 11
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of SLC7A11 mRNA
CTD
PMID:32251684
NCBI chr 3:50,319,385...50,403,947
Ensembl chr 3:49,846,975...50,398,063
G
Slc7a5
solute carrier family 7 (cationic amino acid transporter, y+ system), member 5
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of SLC7A5 mRNA
CTD
PMID:32251684
NCBI chr 8:122,607,885...122,634,425
Ensembl chr 8:122,607,889...122,634,433
G
Sln
sarcolipin
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of SLN mRNA
CTD
PMID:26377693
NCBI chr 9:53,757,535...53,761,133
Ensembl chr 9:53,757,448...53,761,844
G
Smpd3
sphingomyelin phosphodiesterase 3, neutral
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of SMPD3 mRNA
CTD
PMID:26377693
NCBI chr 8:106,979,180...107,064,597
Ensembl chr 8:106,979,180...107,064,620
G
Snai1
snail family zinc finger 1
multiple interactions increases expression
ISO
Acetylcysteine inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of SNAI1 mRNA]; SB 203580 inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of SNAI1 mRNA]
CTD
PMID:21635667
NCBI chr 2:167,380,115...167,384,734
Ensembl chr 2:167,380,115...167,384,734
G
Snord123
small nucleolar RNA, C/D box 123
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of SNORD123 mRNA
CTD
PMID:26377693
NCBI chr15:32,241,991...32,242,078
Ensembl chr15:32,241,999...32,242,069
G
Sox17
SRY (sex determining region Y)-box 17
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of SOX17 mRNA
CTD
PMID:26377693
NCBI chr 1:4,561,154...4,567,624
Ensembl chr 1:4,561,154...4,567,577
G
Sox2
SRY (sex determining region Y)-box 2
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of SOX2 mRNA
CTD
PMID:35687267
NCBI chr 3:34,704,144...34,706,610
Ensembl chr 3:34,704,554...34,706,610
G
Stc2
stanniocalcin 2
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of STC2 mRNA
CTD
PMID:32251684
NCBI chr11:31,309,441...31,320,061
Ensembl chr11:31,307,307...31,320,074
G
Stip1
stress-induced phosphoprotein 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of STIP1 mRNA
CTD
PMID:26377693
NCBI chr19:6,998,064...7,017,394
Ensembl chr19:6,998,070...7,017,335
G
Sulf1
sulfatase 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of SULF1 mRNA
CTD
PMID:26377693
NCBI chr 1:12,762,421...12,946,090
Ensembl chr 1:12,762,501...12,931,416
G
Sult5a1
sulfotransferase family 5A, member 1
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of SULT1A1 mRNA
CTD
PMID:26377693
NCBI chr 8:123,869,582...123,885,170
Ensembl chr 8:123,866,931...123,885,054
G
Syt1
synaptotagmin I
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of SYT1 mRNA
CTD
PMID:26377693
NCBI chr10:108,333,511...108,846,852
Ensembl chr10:108,333,511...108,846,843
G
Tdo2
tryptophan 2,3-dioxygenase
multiple interactions increases expression
ISO
1-methyltryptophan inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of TDO2 protein]; epacadostat inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of TDO2 protein]
CTD
PMID:35687267
NCBI chr 3:81,865,719...81,883,035
Ensembl chr 3:81,864,397...81,883,509
G
Tfap2c
transcription factor AP-2, gamma
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of TFAP2C mRNA
CTD
PMID:32251684
NCBI chr 2:172,387,599...172,400,542
Ensembl chr 2:172,391,513...172,400,542
G
Tff1
trefoil factor 1
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of TFF1 mRNA
CTD
PMID:32251684
NCBI chr17:31,380,369...31,384,034
Ensembl chr17:31,380,369...31,384,251
G
Tff3
trefoil factor 3, intestinal
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of TFF3 mRNA
CTD
PMID:26377693
NCBI chr17:31,344,280...31,348,585
Ensembl chr17:31,344,280...31,348,620
G
Thrsp
thyroid hormone responsive
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of THRSP mRNA
CTD
PMID:26377693
NCBI chr 7:97,062,140...97,066,757
Ensembl chr 7:97,062,145...97,066,937
G
Timp1
tissue inhibitor of metalloproteinase 1
increases expression decreases expression
ISO EXP
indeno(1,2,3-cd)pyrene results in increased expression of TIMP1 mRNA indeno(1,2,3-cd)pyrene results in decreased expression of TIMP1 mRNA
CTD
PMID:22579512 PMID:26377693
NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974
G
Tln2
talin 2
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of TLN2 mRNA
CTD
PMID:21635667
NCBI chr 9:67,124,371...67,541,357
Ensembl chr 9:67,124,369...67,466,985
G
Tmeff1
transmembrane protein with EGF-like and two follistatin-like domains 1
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of TMEFF1 mRNA
CTD
PMID:32251684
NCBI chr 4:48,585,064...48,663,136
Ensembl chr 4:48,585,174...48,663,131
G
Tmem245
transmembrane protein 245
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of TMEM245 mRNA
CTD
PMID:26377693
NCBI chr 4:56,866,923...56,947,456
Ensembl chr 4:56,866,923...56,947,437
G
Tmem45b
transmembrane protein 45b
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of TMEM45B mRNA
CTD
PMID:26377693
NCBI chr 9:31,336,445...31,375,534
Ensembl chr 9:31,337,492...31,375,758
G
Tnni3
troponin I, cardiac 3
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of TNNI3 mRNA
CTD
PMID:26377693
NCBI chr 7:4,521,304...4,526,228
Ensembl chr 7:4,521,304...4,527,228
G
Tnnt2
troponin T2, cardiac
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of TNNT2 mRNA
CTD
PMID:26377693
NCBI chr 1:135,763,933...135,780,006
Ensembl chr 1:135,764,092...135,779,998
G
Tox2
TOX high mobility group box family member 2
multiple interactions
EXP
[indeno(1,2,3-cd)pyrene co-treated with Antigens, Dermatophagoides] results in increased expression of TOX2 mRNA
CTD
PMID:36975775
NCBI chr 2:163,045,047...163,166,092
Ensembl chr 2:163,045,045...163,166,090
G
Trpv4
transient receptor potential cation channel, subfamily V, member 4
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of TRPV4 mRNA
CTD
PMID:26377693
NCBI chr 5:114,760,213...114,796,497
Ensembl chr 5:114,760,213...114,796,482
G
Tsc22d3
TSC22 domain family, member 3
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of TSC22D3 mRNA
CTD
PMID:26377693
NCBI chr X:139,440,277...139,501,257
Ensembl chr X:139,440,277...139,501,408
G
Tspear
thrombospondin type laminin G domain and EAR repeats
increases expression
ISO
indeno(1,2,3-cd)pyrene results in increased expression of TSPEAR mRNA
CTD
PMID:32251684
NCBI chr10:77,521,942...77,722,844
Ensembl chr10:77,522,403...77,722,855
G
Ucp1
uncoupling protein 1 (mitochondrial, proton carrier)
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of UCP1 mRNA
CTD
PMID:26377693
NCBI chr 8:84,016,977...84,025,085
Ensembl chr 8:84,016,981...84,025,081
G
Upk3b
uroplakin 3B
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of UPK3B mRNA
CTD
PMID:26377693
NCBI chr 5:136,067,350...136,073,847
Ensembl chr 5:136,067,350...136,075,341
G
Vav3
vav 3 oncogene
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of VAV3 mRNA
CTD
PMID:21635667
NCBI chr 3:109,247,757...109,593,010
Ensembl chr 3:109,247,969...109,593,014
G
Wdr62
WD repeat domain 62
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of WDR62 mRNA
CTD
PMID:26377693
NCBI chr 7:29,939,563...29,980,243
Ensembl chr 7:29,939,563...29,979,844
G
Wt1
WT1 transcription factor
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of WT1 mRNA
CTD
PMID:26377693
NCBI chr 2:104,956,874...105,003,959
Ensembl chr 2:104,956,874...105,003,961
G
Xbp1
X-box binding protein 1
decreases expression
ISO
indeno(1,2,3-cd)pyrene results in decreased expression of XBP1 mRNA
CTD
PMID:32251684
NCBI chr11:5,470,641...5,475,993
Ensembl chr11:5,470,659...5,475,893
G
Zdhhc22
zinc finger, DHHC-type containing 22
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of ZDHHC22 mRNA
CTD
PMID:26377693
NCBI chr12:87,027,537...87,037,604
Ensembl chr12:87,027,537...87,037,204
G
Zfp628
zinc finger protein 628
decreases expression
EXP
indeno(1,2,3-cd)pyrene results in decreased expression of ZFP628 mRNA
CTD
PMID:26377693
NCBI chr 7:4,918,221...4,925,001
Ensembl chr 7:4,918,216...4,925,001
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
22178
chemical entity
22208
group
22072
polyatomic entity
22072
molecule
21699
cyclic compound
21253
organic cyclic compound
21252
organic polycyclic compound
17940
pyrenes
335
1,2-dihydropyrene-2-carboxylic acid
0
1,3-Dinitropyrene
13
1,6-Dihydroxypyrene
0
1,6-Dimethoxypyrene
0
1,6-Dinitropyrene
3
1,8-Dihydroxypyrene
0
1,8-Dinitropyrene
12
1-Aminopyrene
10
1-Hydroxy-6-methoxypyrene
0
1-Hydroxypyrene
54
1-Hydroxypyrene glucuronide
0
1-Methoxypyrene
0
1-Methylpyrene
3
1-Pyrenylsulfate
0
10-Oxabenzo[def]chrysen-9-one
0
2-(2-pyrenyl)acetonitrile
0
2-Hydroxypyrene
0
2-Nitropyrene
0
4,5-Dihydroxypyrene
0
4-(1-Pyrenyl)butyl N-[(9H-fluoren-9-ylmethoxy)carbonyl]valinate
0
4-Nitropyrene
1
Acepyrene
0
Benzo[a]pyrene-7,8-diol
29
Benzo[a]pyrene-7,8-oxide
2
Benzo[a]pyrene-9,10-oxide
0
Benzo[a]pyrene-cis-9,10-dihydrodiol
0
Cyclopenta[cd]pyrene
2
Indeno[1,2,3-cd]pyrene
250
N,N'-Bis(1-pyrenylmethyl)isophthalamide
0
Pyrene-1,6-dione
0
Pyrene-1,8-dione
0
Pyrene-4,5-dione
0
benzo[a]pyrene-7,8-dione
17
benzo[a]pyrene-cis-7,8-dihydrodiol +
17
cis-4-(7-Hydroxtpyren-8-yl)-2-oxobut-3-enoate
0
cis-4-(8-Hydroxypyren-7-yl)-2-oxobut-3-enoate
0
Path 2
CHEBI ontology
22178
subatomic particle
22170
composite particle
22170
hadron
22201
baryon
22170
nucleon
22170
atomic nucleus
22170
atom
22170
main group element atom
22104
p-block element atom
22104
p-block molecular entity
22104
carbon group molecular entity
21904
organic molecular entity
21830
organic molecule
21647
organic cyclic compound
21252
organic polycyclic compound
17940
pyrenes
335
1,2-dihydropyrene-2-carboxylic acid
0
1,3-Dinitropyrene
13
1,6-Dihydroxypyrene
0
1,6-Dimethoxypyrene
0
1,6-Dinitropyrene
3
1,8-Dihydroxypyrene
0
1,8-Dinitropyrene
12
1-Aminopyrene
10
1-Hydroxy-6-methoxypyrene
0
1-Hydroxypyrene
54
1-Hydroxypyrene glucuronide
0
1-Methoxypyrene
0
1-Methylpyrene
3
1-Pyrenylsulfate
0
10-Oxabenzo[def]chrysen-9-one
0
2-(2-pyrenyl)acetonitrile
0
2-Hydroxypyrene
0
2-Nitropyrene
0
4,5-Dihydroxypyrene
0
4-(1-Pyrenyl)butyl N-[(9H-fluoren-9-ylmethoxy)carbonyl]valinate
0
4-Nitropyrene
1
Acepyrene
0
Benzo[a]pyrene-7,8-diol
29
Benzo[a]pyrene-7,8-oxide
2
Benzo[a]pyrene-9,10-oxide
0
Benzo[a]pyrene-cis-9,10-dihydrodiol
0
Cyclopenta[cd]pyrene
2
Indeno[1,2,3-cd]pyrene
250
N,N'-Bis(1-pyrenylmethyl)isophthalamide
0
Pyrene-1,6-dione
0
Pyrene-1,8-dione
0
Pyrene-4,5-dione
0
benzo[a]pyrene-7,8-dione
17
benzo[a]pyrene-cis-7,8-dihydrodiol +
17
cis-4-(7-Hydroxtpyren-8-yl)-2-oxobut-3-enoate
0
cis-4-(8-Hydroxypyren-7-yl)-2-oxobut-3-enoate
0